Skip to content
RNAWiki
Checking…
All public datasets

Public dataset

Recorded source agreement and disagreement

Show whether sources print one normalized reading, have incompatible units, lack structured comparison context, or contain a context-matched numeric difference.

What this does not mean: agree can mean only that sources print the same normalized reading; it is not clinical-context equivalence, independent replication, or proof. differ requires matching structured context and disjoint comparable values. not_comparable and insufficient_context are not disagreement.
Public rows
1,681
Generated
Schema version
source-consensus/2

Coverage

What this run contains

Compared medicine fields
1,681
Agree
1,282
Differ
0
Not comparable
12
Insufficient context
387
Fields represented
5
bioavailability, halfLife, proteinBinding, tMax, volumeOfDistribution

Method

How the rows were made

  1. Deterministic rules normalize recorded pharmacokinetic readings and compare only like-for-like values.
  2. One normalized printed reading may be agree even when clinical context was not extracted; this reports printed-reading agreement only.
  3. Distinct readings may differ only when their units and denominators are comparable and one matching, non-placeholder population/formulation context was structurally extracted. Otherwise they are insufficient_context.
  4. not_comparable preserves incompatible units or denominators instead of guessing. insufficient_context preserves missing or non-matching structured context instead of manufacturing agreement or disagreement.
  5. The agreement rate describes the distribution of recorded source readings; it is not a probability that a value is true.
  6. Every distinct printed reading retains its unit, population context, source count, and complete source records. The API paginates field rows, never child readings or sources.
  7. documentsExamined is every matching single-substance archive document inspected for that medicine. The generator has no document, reading, or source ceiling, so there is no hidden available-versus-retained remainder.

Limits

Read these before using a row

  • Current label parsing does not structurally extract population or formulation context. Distinct otherwise-comparable readings are therefore insufficient_context, never differ; agree may mean printed-reading agreement only. Source records are complete but are not independent-experiment counts.
  • The current deterministic parser does not structurally extract population or formulation context from these sentences. It records that context as unknown and cannot publish distinct same-unit readings as differ.
  • Neither reading is marked wrong. Population, formulation, route, and other unextracted context may explain the printed difference.
  • Only the recorded fields and source documents in this snapshot are compared.
  • A source count is the number of retained source records in the row, not a count of independent experiments.

Provenance

Source examples

abacavir · bioavailability · agree

15 documents examined; 83% (Unknown: population and formulation context were not structurally extracted from this source sentence.)

FDA_LABEL:5676d391-f9a4-44be-9604-954b3d8d0e2b (opens source in a new tab)
The geometric mean absolute bioavailability of the tablet was 83%.

alemtuzumab · volumeOfDistribution · not_comparable

2 documents examined; 0.18 L/kg (Unknown: population and formulation context were not structurally extracted from this source sentence.); 14.1 L (Unknown: population and formulation context were not structurally extracted from this source sentence.)

FDA_LABEL:4f5f7255-7abc-4328-bd1a-ceaf139ef3e0 (opens source in a new tab)
Distribution After the last 30 mg dose, the mean volume of distribution at steady-state was 0.18 L/kg (range 0.1 to 0.4 L/kg).

abiraterone · halfLife · insufficient_context

31 documents examined; 12 ± 5 hours (Unknown: population and formulation context were not structurally extracted from this source sentence.); 18 hours (Unknown: population and formulation context were not structurally extracted from this source sentence.)

FDA_LABEL:c9eb9b46-f847-40a8-802c-a51b40406d5a (opens source in a new tab)
Elimination In patients with metastatic CRPC, the mean terminal half-life of abiraterone in plasma (mean ± SD) is 12 ± 5 hours.

Artifact used for this view: data/source-consensus.ndjson. The reader resolves the current run first and uses the checked-in compatibility run only when a current artifact is absent.

Schema

Fields in the public projection

FieldTypeMeaning
medicineSlugstringStable RNAWiki medicine route key.
fieldstringRecorded pharmacokinetic field being compared.
comparisonStatestringagree (printed-reading agreement), differ (context-matched comparable disjoint values), not_comparable (unit/denominator mismatch), or insufficient_context. Every state remains declared even when its current count is zero.
comparisonReasonsstring[]Deterministic codes explaining the state.
documentsExaminednumberRecorded source documents considered for the field.
sourceCountnumberRecorded source readings represented.
agreementRatenumberShare represented by the leading normalized printed-reading group; not a confidence score or clinical agreement probability.
readingsconsensus-reading[]Complete, untruncated reading groups. Each keeps the printed display, numeric value when parsed, unit, population context, source count, and every source identity, version/effective date or explicit absence, retrieval date, locator, safe link, and excerpt.

Reader

Search and filter the rows

Case-insensitive text search over the public fields named for this dataset.

Exact comparability state.

Exact recorded field key.

Clear

Showing 1,621–1,630 of 1,681 matching rows. Filters and search terms remain attached when you move between pages or open the API view.

  1. Projected row 1621

    Medicine slug
    venlafaxine
    Compared field
    halfLife
    Comparison state
    insufficient_context
    Reason codes
    • STRUCTURED_CONTEXT_MISSING
    Documents examined
    178
    Source count
    157
    Agreement rate
    0.547771
    Recorded readings

    1. 5 ± 2 hours

      Numeric value
      5
      Unit
      hours
      Source records
      86

      Population and context: Unknown: population and formulation context were not structurally extracted from this source sentence.

      Show all 86 source records
      1. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:33068acd-d361-4cd9-b994-02a7865ff04f (opens source in a new tab)

        Venlafaxine label

        Version not recorded · Effective date not recorded

        The apparent elimination half-life is 5 ± 2 hours for venlafaxine and 11 ± 2 hours for ODV.
      2. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:ea5914ab-28f3-4cb3-bade-6eaccac214e4 (opens source in a new tab)

        Venlafaxine label

        Version not recorded · Effective date not recorded

        The apparent elimination half-life is 5±2 hours for venlafaxine and 11±2 hours for ODV.
      3. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:9c061460-3b80-41e1-a87a-1a25108ff740 (opens source in a new tab)

        Venlafaxine label

        Version not recorded · Effective date not recorded

        The apparent elimination half-life is 5 ± 2 hours for venlafaxine and 11 ± 2 hours for ODV.
      4. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:f8fd4381-52f2-d9c1-e053-6394a90a08e5 (opens source in a new tab)

        Venlafaxine label

        Version not recorded · Effective date not recorded

        The apparent elimination half-life is 5 ± 2 hours for venlafaxine and 11 ± 2 hours for ODV.
      5. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:15c77ad7-7edc-4c36-ba3f-3ef05dfb12dc (opens source in a new tab)

        Venlafaxine label

        Version not recorded · Effective date not recorded

        The apparent elimination half-life is 5 ± 2 hours for venlafaxine and 11 ± 2 hours for ODV.
      6. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:5c943206-6df8-4fc5-ab1d-d34b9715182c (opens source in a new tab)

        Venlafaxine label

        Version not recorded · Effective date not recorded

        The apparent elimination half-life is 5 ± 2 hours for venlafaxine and 11 ± 2 hours for ODV.
      7. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:ac9b972d-8b8a-4727-90c2-b208f91272fd (opens source in a new tab)

        Venlafaxine label

        Version not recorded · Effective date not recorded

        The apparent elimination half-life is 5 ± 2 hours for venlafaxine and 11 ± 2 hours for ODV.
      8. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:0a1b6bcd-8d46-44ab-bc5d-65515601d2ff (opens source in a new tab)

        Venlafaxine label

        Version not recorded · Effective date not recorded

        The apparent elimination half-life is 5±2 hours for venlafaxine and 11±2 hours for ODV.
      9. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:8d6e699b-24bf-4e77-8a7f-acd496a700c7 (opens source in a new tab)

        Venlafaxine label

        Version not recorded · Effective date not recorded

        The apparent elimination half-life is 5 ± 2 hours for venlafaxine and 11 ± 2 hours for ODV.
      10. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:e1114c1d-c193-4c0c-ad1c-c17b3fc61723 (opens source in a new tab)

        Venlafaxine label

        Version not recorded · Effective date not recorded

        The apparent elimination half-life is 5 ± 2 hours for venlafaxine and 11 ± 2 hours for ODV.
      11. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:0ee91447-2c23-4519-81cc-550b5416dd6b (opens source in a new tab)

        Venlafaxine label

        Version not recorded · Effective date not recorded

        The apparent elimination half-life is 5 ± 2 hours for venlafaxine and 11 ± 2 hours for ODV.
      12. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:c4312b7b-7a42-45f1-b6e6-e20ea76020c4 (opens source in a new tab)

        Venlafaxine label

        Version not recorded · Effective date not recorded

        The apparent elimination half-life is 5 ± 2 hours for venlafaxine and 11 ± 2 hours for ODV.
      13. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:4a007068-89d9-c296-e063-6394a90ad6d0 (opens source in a new tab)

        Venlafaxine label

        Version not recorded · Effective date not recorded

        The apparent elimination half-life is 5 ± 2 hours for venlafaxine and 11 ± 2 hours for ODV.
      14. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:d7d1319c-500e-4ca0-83a1-a739cfa01cf7 (opens source in a new tab)

        Venlafaxine label

        Version not recorded · Effective date not recorded

        The apparent elimination half-life is 5±2 hours for venlafaxine and 11±2 hours for ODV.
      15. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:7852be9e-0c1d-47a8-9513-c3a04b365763 (opens source in a new tab)

        Venlafaxine label

        Version not recorded · Effective date not recorded

        The apparent elimination half-life is 5 ± 2 hours for venlafaxine and 11 ± 2 hours for ODV.
      16. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:5359012e-a868-3aa3-e063-6294a90a74e2 (opens source in a new tab)

        Venlafaxine label

        Version not recorded · Effective date not recorded

        The apparent elimination half-life is 5 ± 2 hours for venlafaxine and 11 ± 2 hours for ODV.
      17. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:b865c175-e75d-4cb4-ac29-dec72226302c (opens source in a new tab)

        Venlafaxine label

        Version not recorded · Effective date not recorded

        The apparent elimination half-life is 5 ± 2 hours for venlafaxine and 11 ± 2 hours for ODV.
      18. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:430777f0-347c-4f21-8c5d-55f4e9897e74 (opens source in a new tab)

        Venlafaxine label

        Version not recorded · Effective date not recorded

        The apparent elimination half-life is 5±2 hours for venlafaxine and 11±2 hours for ODV.
      19. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:c69d16fd-b82d-4708-aece-ab4f60b29cc6 (opens source in a new tab)

        Venlafaxine label

        Version not recorded · Effective date not recorded

        The apparent elimination half-life is 5 ± 2 hours for venlafaxine and 11 ± 2 hours for ODV.
      20. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:963e5599-f9af-45c2-8cf4-13cf52eed6a0 (opens source in a new tab)

        Venlafaxine label

        Version not recorded · Effective date not recorded

        The apparent elimination half-life is 5±2 hours for venlafaxine and 11±2 hours for ODV.
      21. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:1e1119f7-0c2e-4587-a24d-0066f73b2e65 (opens source in a new tab)

        Venlafaxine label

        Version not recorded · Effective date not recorded

        The apparent elimination half-life is 5 ± 2 hours for venlafaxine and 11 ± 2 hours for ODV.
      22. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:baae24d6-e425-4cfc-9a53-3cd223b6d344 (opens source in a new tab)

        Venlafaxine label

        Version not recorded · Effective date not recorded

        The apparent elimination half-life is 5 ± 2 hours for venlafaxine and 11 ± 2 hours for ODV.
      23. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:2c2bb0e6-5a73-ff57-e063-6294a90a88d3 (opens source in a new tab)

        Venlafaxine label

        Version not recorded · Effective date not recorded

        The apparent elimination half-life is 5 ± 2 hours for venlafaxine and 11 ± 2 hours for ODV.
      24. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:5351fe67-17d9-42ec-9e8b-6585fdb9e29e (opens source in a new tab)

        Venlafaxine label

        Version not recorded · Effective date not recorded

        The apparent elimination half-life is 5 ± 2 hours for venlafaxine and 11 ± 2 hours for ODV.
      25. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:33b39416-7981-46fb-ba31-e933a6afcf8b (opens source in a new tab)

        Venlafaxine label

        Version not recorded · Effective date not recorded

        The apparent elimination half-life is 5±2 hours for venlafaxine and 11±2 hours for ODV.
      26. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:92b3f73d-d6ca-4d7d-9035-5700f527cb85 (opens source in a new tab)

        Venlafaxine label

        Version not recorded · Effective date not recorded

        The apparent elimination half-life is 5±2 hours for venlafaxine and 11±2 hours for ODV.
      27. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:9fda0f8d-b24e-4581-9dca-7aaaf86e2413 (opens source in a new tab)

        Venlafaxine label

        Version not recorded · Effective date not recorded

        The apparent elimination half-life is 5 ± 2 hours for venlafaxine and 11 ± 2 hours for ODV.
      28. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:4992698e-5d5a-6468-e063-6394a90ab404 (opens source in a new tab)

        Venlafaxine label

        Version not recorded · Effective date not recorded

        The apparent elimination half-life is 5 ± 2 hours for venlafaxine and 11 ± 2 hours for ODV.
      29. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:812ca864-8230-4c84-a7f4-d1b926dee31a (opens source in a new tab)

        Venlafaxine label

        Version not recorded · Effective date not recorded

        The apparent elimination half-life is 5 ± 2 hours for venlafaxine and 11 ± 2 hours for ODV.
      30. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:7fcd7995-81fb-4368-bd4c-3726b2ae363e (opens source in a new tab)

        Venlafaxine label

        Version not recorded · Effective date not recorded

        The apparent elimination half-life is 5±2 hours for venlafaxine and 11±2 hours for ODV.
      31. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:c37a73fa-ceee-4555-a61b-e1e66ad6e97d (opens source in a new tab)

        Venlafaxine label

        Version not recorded · Effective date not recorded

        The apparent elimination half-life is 5±2 hours for venlafaxine and 11±2 hours for ODV.
      32. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:4e3053b9-cdec-4f4d-85ae-2e55cf1cc185 (opens source in a new tab)

        Venlafaxine label

        Version not recorded · Effective date not recorded

        The apparent elimination half-life is 5 ± 2 hours for venlafaxine and 11 ± 2 hours for ODV.
      33. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:f757cac4-efa7-668c-e053-6294a90a720d (opens source in a new tab)

        Venlafaxine label

        Version not recorded · Effective date not recorded

        The apparent elimination half-life is 5 ± 2 hours for venlafaxine and 11 ± 2 hours for ODV.
      34. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:b18d726e-cdb2-4c80-a49d-330cddee17e9 (opens source in a new tab)

        Venlafaxine label

        Version not recorded · Effective date not recorded

        The apparent elimination half-life is 5 ± 2 hours for venlafaxine and 11 ± 2 hours for ODV.
      35. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:6c1d0d4f-c8e2-4035-8f4e-7a46bfe3f059 (opens source in a new tab)

        Venlafaxine label

        Version not recorded · Effective date not recorded

        The apparent elimination half-life is 5 ± 2 hours for venlafaxine and 11 ± 2 hours for ODV.
      36. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:04340ccb-c3b3-41ab-a4bc-101d8b6bc1a9 (opens source in a new tab)

        Venlafaxine label

        Version not recorded · Effective date not recorded

        The apparent elimination half-life is 5 ± 2 hours for venlafaxine and 11 ± 2 hours for ODV.
      37. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:20a7d922-7f7c-4de4-b5fd-55c13aab060c (opens source in a new tab)

        Venlafaxine label

        Version not recorded · Effective date not recorded

        The apparent elimination half-life is 5 ± 2 hours for venlafaxine and 11 ± 2 hours for ODV.
      38. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:2efde38c-250e-d1b9-e063-6394a90a1b74 (opens source in a new tab)

        Venlafaxine label

        Version not recorded · Effective date not recorded

        The apparent elimination half-life is 5 ± 2 hours for venlafaxine and 11 ± 2 hours for ODV.
      39. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:2a85bd43-419c-6ed7-e063-6294a90a84d4 (opens source in a new tab)

        Venlafaxine label

        Version not recorded · Effective date not recorded

        The apparent elimination half-life is 5±2 hours for venlafaxine and 11±2 hours for ODV.
      40. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:bce7adf8-b4b5-4d7f-bf0d-ae1277ae3a2b (opens source in a new tab)

        Venlafaxine label

        Version not recorded · Effective date not recorded

        The apparent elimination half-life is 5±2 hours for venlafaxine and 11±2 hours for ODV.
      41. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:e05bdeb4-07a9-441e-901b-f2aea550db2b (opens source in a new tab)

        Venlafaxine label

        Version not recorded · Effective date not recorded

        The apparent elimination half-life is 5 ± 2 hours for venlafaxine and 11 ± 2 hours for ODV.
      42. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:35d3148b-52f3-197c-e063-6294a90a44e3 (opens source in a new tab)

        Venlafaxine label

        Version not recorded · Effective date not recorded

        The apparent elimination half-life is 5 ± 2 hours for venlafaxine and 11 ± 2 hours for ODV.
      43. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:19b1543e-d599-a869-e063-6294a90a8e28 (opens source in a new tab)

        Venlafaxine label

        Version not recorded · Effective date not recorded

        The apparent elimination half-life is 5±2 hours for venlafaxine and 11±2 hours for ODV.
      44. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:2787aaa2-5210-f7d5-e063-6294a90a7103 (opens source in a new tab)

        Venlafaxine label

        Version not recorded · Effective date not recorded

        The apparent elimination half-life is 5 ± 2 hours for venlafaxine and 11 ± 2 hours for ODV.
      45. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:f89bcae0-e714-599a-e053-6294a90a2c3a (opens source in a new tab)

        Venlafaxine label

        Version not recorded · Effective date not recorded

        The apparent elimination half-life is 5 ± 2 hours for venlafaxine and 11 ± 2 hours for ODV.
      46. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:b1d21366-f686-4e20-a10f-0c25f517db38 (opens source in a new tab)

        Venlafaxine label

        Version not recorded · Effective date not recorded

        The apparent elimination half-life is 5±2 hours for venlafaxine and 11±2 hours for ODV.
      47. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:3e51f786-3691-4ec4-836b-7f2c9a385aa7 (opens source in a new tab)

        Venlafaxine label

        Version not recorded · Effective date not recorded

        The apparent elimination half-life is 5 ± 2 hours for venlafaxine and 11 ± 2 hours for ODV.
      48. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:1a9e207a-aba5-4ecb-b7b6-7c1e38be5ac9 (opens source in a new tab)

        Venlafaxine label

        Version not recorded · Effective date not recorded

        The apparent elimination half-life is 5 ± 2 hours for venlafaxine and 11 ± 2 hours for ODV.
      49. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:1bf78b22-a0e3-5f9f-e063-6394a90a3024 (opens source in a new tab)

        Venlafaxine label

        Version not recorded · Effective date not recorded

        The apparent elimination half-life is 5±2 hours for venlafaxine and 11±2 hours for ODV.
      50. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:9e745ad7-be4f-4369-be23-587e1154e4ab (opens source in a new tab)

        Venlafaxine label

        Version not recorded · Effective date not recorded

        The apparent elimination half-life is 5 ± 2 hours for venlafaxine and 11 ± 2 hours for ODV.
      51. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:67059969-e291-4609-b130-0faacf2a19f0 (opens source in a new tab)

        Venlafaxine label

        Version not recorded · Effective date not recorded

        The apparent elimination half-life is 5 ± 2 hours for venlafaxine and 11 ± 2 hours for ODV.
      52. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:48a75840-64e4-4d44-9a62-009373003105 (opens source in a new tab)

        Venlafaxine label

        Version not recorded · Effective date not recorded

        The apparent elimination half-life is 5 ± 2 hours for venlafaxine and 11 ± 2 hours for ODV.
      53. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:9a30e1b5-272b-4109-ad6c-a3c9a895822f (opens source in a new tab)

        Venlafaxine label

        Version not recorded · Effective date not recorded

        The apparent elimination half-life is 5 ± 2 hours for venlafaxine and 11 ± 2 hours for ODV.
      54. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:3c2e188f-76aa-a022-e063-6294a90abfc9 (opens source in a new tab)

        Venlafaxine label

        Version not recorded · Effective date not recorded

        The apparent elimination half-life is 5 ± 2 hours for venlafaxine and 11 ± 2 hours for ODV.
      55. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:bff505db-2752-41fc-a4dd-4773f629106e (opens source in a new tab)

        Venlafaxine label

        Version not recorded · Effective date not recorded

        The apparent elimination half-life is 5 ± 2 hours for venlafaxine and 11 ± 2 hours for ODV.
      56. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:85d3ce8b-8966-45d9-bdaf-f6f0475096e1 (opens source in a new tab)

        Venlafaxine label

        Version not recorded · Effective date not recorded

        The apparent elimination half-life is 5 ± 2 hours for venlafaxine and 11 ± 2 hours for ODV.
      57. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:5c558ab8-b4b3-4973-b016-ed5cfcb4d88b (opens source in a new tab)

        Venlafaxine label

        Version not recorded · Effective date not recorded

        The apparent elimination half-life is 5 ± 2 hours for venlafaxine and 11 ± 2 hours for ODV.
      58. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:c848a5d8-ba94-4c84-80e3-0bf35fb8e32e (opens source in a new tab)

        Venlafaxine label

        Version not recorded · Effective date not recorded

        The apparent elimination half-life is 5 ± 2 hours for venlafaxine and 11 ± 2 hours for ODV.
      59. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:0c404290-2806-4756-bca3-2d639b400963 (opens source in a new tab)

        Venlafaxine label

        Version not recorded · Effective date not recorded

        The apparent elimination half-life is 5 ± 2 hours for venlafaxine and 11 ± 2 hours for ODV.
      60. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:85740bf6-7e88-4a6e-9ec9-3455e3b95e59 (opens source in a new tab)

        Venlafaxine label

        Version not recorded · Effective date not recorded

        The apparent elimination half-life is 5 ± 2 hours for venlafaxine and 11 ± 2 hours for ODV.
      61. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:e3e238db-4388-49bb-aa67-6d73adbb2280 (opens source in a new tab)

        Venlafaxine label

        Version not recorded · Effective date not recorded

        The apparent elimination half-life is 5 ± 2 hours for venlafaxine and 11 ± 2 hours for ODV.
      62. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:7588ffdc-034d-4baf-9889-9a0ded265be5 (opens source in a new tab)

        Venlafaxine label

        Version not recorded · Effective date not recorded

        The apparent elimination half-life is 5 ± 2 hours for venlafaxine and 11 ± 2 hours for ODV.
      63. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:e2fa1bb0-ab86-4499-84cb-ff5e02a16991 (opens source in a new tab)

        Venlafaxine label

        Version not recorded · Effective date not recorded

        The apparent elimination half-life is 5 ± 2 hours for venlafaxine and 11 ± 2 hours for ODV.
      64. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:0aedeaf8-9b6c-4a44-a5fe-9d74516f542d (opens source in a new tab)

        Venlafaxine label

        Version not recorded · Effective date not recorded

        The apparent elimination half-life is 5 ± 2 hours for venlafaxine and 11 ± 2 hours for ODV.
      65. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:22980b32-cbae-4f37-9fc0-b47221b2c32e (opens source in a new tab)

        Venlafaxine label

        Version not recorded · Effective date not recorded

        The apparent elimination half-life is 5 ± 2 hours for venlafaxine and 11 ± 2 hours for ODV.
      66. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:de6e30f8-c8ef-4016-b228-0f188645347b (opens source in a new tab)

        Venlafaxine label

        Version not recorded · Effective date not recorded

        The apparent elimination half-life is 5 ± 2 hours for venlafaxine and 11 ± 2 hours for ODV.
      67. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:e2d5a2d5-5e55-426c-bc8d-d29729eba775 (opens source in a new tab)

        Venlafaxine label

        Version not recorded · Effective date not recorded

        The apparent elimination half-life is 5 ± 2 hours for venlafaxine and 11 ± 2 hours for ODV.
      68. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:28c8f404-1dbd-4140-8959-32624d7c7724 (opens source in a new tab)

        Venlafaxine label

        Version not recorded · Effective date not recorded

        The apparent elimination half-life is 5 ± 2 hours for venlafaxine and 11 ± 2 hours for ODV.
      69. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:2a7d760c-fd9f-8026-e063-6294a90aaa43 (opens source in a new tab)

        Venlafaxine label

        Version not recorded · Effective date not recorded

        The apparent elimination half-life is 5 ± 2 hours for venlafaxine and 11 ± 2 hours for ODV.
      70. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:1775b8bf-cd4f-4a8a-abd1-78d90de54fdd (opens source in a new tab)

        Venlafaxine label

        Version not recorded · Effective date not recorded

        The apparent elimination half-life is 5 ± 2 hours for venlafaxine and 11 ± 2 hours for ODV.
      71. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:d94e5404-f728-4e4b-af99-8a8e4dfae227 (opens source in a new tab)

        Venlafaxine label

        Version not recorded · Effective date not recorded

        The apparent elimination half-life is 5±2 hours for venlafaxine and 11±2 hours for ODV.
      72. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:f50029b8-7d05-445a-9d9f-71a1aee6088b (opens source in a new tab)

        Venlafaxine label

        Version not recorded · Effective date not recorded

        The apparent elimination half-life is 5±2 hours for venlafaxine and 11±2 hours for ODV.
      73. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:f5c21429-d5d0-9f93-a465-6e5e0e19ebdd (opens source in a new tab)

        Venlafaxine label

        Version not recorded · Effective date not recorded

        The apparent elimination half-life is 5 ± 2 hours for venlafaxine and 11 ± 2 hours for ODV.
      74. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:1e04fe02-88c9-dafd-e063-6294a90ac4c9 (opens source in a new tab)

        Venlafaxine label

        Version not recorded · Effective date not recorded

        The apparent elimination half-life is 5±2 hours for venlafaxine and 11±2 hours for ODV.
      75. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:b055df74-51f9-401f-8cca-24269a0163df (opens source in a new tab)

        Venlafaxine label

        Version not recorded · Effective date not recorded

        The apparent elimination half-life is 5±2 hours for venlafaxine and 11±2 hours for ODV.
      76. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:d962f5af-7642-4c6e-b7be-3e089fe48873 (opens source in a new tab)

        Venlafaxine label

        Version not recorded · Effective date not recorded

        The apparent elimination half-life is 5 ± 2 hours for venlafaxine and 11 ± 2 hours for ODV.
      77. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:c41d847b-88ba-49a5-9d73-269ac4caa4ed (opens source in a new tab)

        Venlafaxine label

        Version not recorded · Effective date not recorded

        The apparent elimination half-life is 5 ± 2 hours for venlafaxine and 11 ± 2 hours for ODV.
      78. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:296d6ab7-8c0c-40e5-8cb2-9d125b42b8bb (opens source in a new tab)

        Venlafaxine label

        Version not recorded · Effective date not recorded

        The apparent elimination half-life is 5 ± 2 hours for venlafaxine and 11 ± 2 hours for ODV.
      79. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:569e10d1-6432-473c-a026-ac438bd77bcd (opens source in a new tab)

        Venlafaxine label

        Version not recorded · Effective date not recorded

        The apparent elimination half-life is 5 ± 2 hours for venlafaxine and 11 ± 2 hours for ODV.
      80. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:3cbe3e18-9a7e-aaa3-e063-6394a90abf92 (opens source in a new tab)

        Venlafaxine label

        Version not recorded · Effective date not recorded

        The apparent elimination half-life is 5 ± 2 hours for venlafaxine and 11 ± 2 hours for ODV.
      81. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:653f3f95-98d0-4ce0-bf10-ac7938be690e (opens source in a new tab)

        Venlafaxine label

        Version not recorded · Effective date not recorded

        The apparent elimination half-life is 5 ± 2 hours for venlafaxine and 11 ± 2 hours for ODV.
      82. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:cb4c04a6-47d1-44ff-8d58-718102fa08eb (opens source in a new tab)

        Venlafaxine label

        Version not recorded · Effective date not recorded

        The apparent elimination half-life is 5 ± 2 hours for venlafaxine and 11 ± 2 hours for ODV.
      83. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:7aa3edba-4248-49bb-86f7-06fdbf2a6fb7 (opens source in a new tab)

        Venlafaxine label

        Version not recorded · Effective date not recorded

        The apparent elimination half-life is 5 ± 2 hours for venlafaxine and 11 ± 2 hours for ODV.
      84. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:5358f20f-b864-0aae-e063-6394a90a7eab (opens source in a new tab)

        Venlafaxine label

        Version not recorded · Effective date not recorded

        The apparent elimination half-life is 5 ± 2 hours for venlafaxine and 11 ± 2 hours for ODV.
      85. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:5a990dbd-f280-4caf-b950-4703ee98b230 (opens source in a new tab)

        Venlafaxine label

        Version not recorded · Effective date not recorded

        The apparent elimination half-life is 5±2 hours for venlafaxine and 11±2 hours for ODV.
      86. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:50d3b487-9f65-4e2f-b6eb-9533964f8972 (opens source in a new tab)

        Venlafaxine label

        Version not recorded · Effective date not recorded

        The apparent elimination half-life is 5 ± 2 hours for venlafaxine and 11 ± 2 hours for ODV.

    2. 11 ± 2 hours

      Numeric value
      11
      Unit
      hours
      Source records
      69

      Population and context: Unknown: population and formulation context were not structurally extracted from this source sentence.

      Show all 69 source records
      1. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:b19ec628-4034-4316-ad3d-46c1ee220728 (opens source in a new tab)

        Venlafaxine label

        Version not recorded · Effective date not recorded

        Mean ± SD steady-state plasma clearance of venlafaxine and ODV is 1.3 ± 0.6 and 0.4 ± 0.2 L/h/kg, respectively; elimination half-life is 5 ± 2 and 11 ± 2 hours, respectively; and steady-state volume of distribution is 7.5 ± 3.7 L/kg and 5.7 ± 1.8 L/kg, respectively.
      2. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:1ce9121b-aaa0-a5bb-e063-6394a90a2f3c (opens source in a new tab)

        Venlafaxine label

        Version not recorded · Effective date not recorded

        Mean ± SD steady-state plasma clearance of venlafaxine and ODV is 1.3 ± 0.6 and 0.4 ± 0.2 L/h/kg, respectively; elimination half-life is 5 ± 2 and 11 ± 2 hours, respectively; and steady-state volume of distribution is 7.5 ± 3.7 L/kg and 5.7 ± 1.8 L/kg, respectively.
      3. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:470ad045-6c82-4e44-8e88-0e2b01a41ff2 (opens source in a new tab)

        Venlafaxine label

        Version not recorded · Effective date not recorded

        Mean ± SD steady-state plasma clearance of venlafaxine and ODV is 1.3 ± 0.6 and 0.4 ± 0.2 L/h/kg, respectively; elimination half-life is 5 ± 2 and 11 ± 2 hours, respectively; and steady-state volume of distribution is 7.5 ± 3.7 L/kg and 5.7 ± 1.8 L/kg, respectively.
      4. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:9f697c00-f5ec-454a-a66c-503aef5fc609 (opens source in a new tab)

        Venlafaxine label

        Version not recorded · Effective date not recorded

        Mean ± SD steady-state plasma clearance of venlafaxine and ODV is 1.3 ± 0.6 and 0.4 ± 0.2 L/h/kg, respectively; apparent elimination half-life is 5 ± 2 and 11 ± 2 hours, respectively; and apparent (steady-state) volume of distribution is 7.5 ± 3.7 and 5.7 ± 1.8 L/kg, respectively.
      5. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:8906ed5a-f69c-0eac-e053-2995a90ae600 (opens source in a new tab)

        Venlafaxine label

        Version not recorded · Effective date not recorded

        Mean±SD steady-state plasma clearance of venlafaxine and ODV is 1.3±0.6 and 0.4±0.2 L/h/kg, respectively; apparent elimination half-life is 5±2 and 11±2 hours, respectively; and apparent (steady-state) volume of distribution is 7.5±3.7 and 5.7±1.8 L/kg, respectively.
      6. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:72efad5f-0909-46a5-aa13-ac24fe015fe6 (opens source in a new tab)

        Venlafaxine label

        Version not recorded · Effective date not recorded

        Mean ± SD steady-state plasma clearance of venlafaxine and ODV is 1.3 ± 0.6 and 0.4 ± 0.2 L/h/kg, respectively; elimination half-life is 5 ± 2 and 11±2 hours, respectively; and steady-state volume of distribution is 7.5 ± 3.7 L/kg and 5.7 ± 1.8 L/kg, respectively.
      7. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:2887a463-2da1-4f8d-afef-f4c88d31e04d (opens source in a new tab)

        Venlafaxine label

        Version not recorded · Effective date not recorded

        Mean ± SD steady-state plasma clearance of venlafaxine and ODV is 1.3 ± 0.6 and 0.4 ± 0.2 L/h/kg, respectively; elimination half-life is 5 ± 2 and 11 ± 2 hours, respectively; and steady-state volume of distribution is 7.5 ± 3.7 L/kg and 5.7 ± 1.8 L/kg, respectively.
      8. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:f02cc6e8-186f-46e8-9675-70fd55d002c4 (opens source in a new tab)

        Venlafaxine label

        Version not recorded · Effective date not recorded

        Mean±SD steady-state plasma clearance of venlafaxine and ODV is 1.3±0.6 and 0.4±0.2 L/h/kg, respectively; apparent elimination half-life is 5±2 and 11±2 hours, respectively; and apparent (steady state) volume of distribution is 7.5±3.7 and 5.7±1.8 L/kg, respectively.
      9. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:38fd2c97-cd30-2f7d-e054-00144ff8d46c (opens source in a new tab)

        Venlafaxine label

        Version not recorded · Effective date not recorded

        Mean ± SD steady-state plasma clearance of venlafaxine and ODV is 1.3 ± 0.6 and 0.4 ± 0.2 L/h/kg, respectively; elimination half-life is 5 ± 2 and 11 ± 2 hours, respectively; and steady-state volume of distribution is 7.5 ± 3.7 L/kg and 5.7 ± 1.8 L/kg, respectively.
      10. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:2ed61dcf-42e3-47cf-a607-459eef5fea98 (opens source in a new tab)

        Venlafaxine label

        Version not recorded · Effective date not recorded

        Mean ± SD steady-state plasma clearance of venlafaxine and ODV is 1.3 ± 0.6 and 0.4 ± 0.2 L/h/kg, respectively; elimination half-life is 5 ± 2 and 11 ± 2 hours, respectively; and steady-state volume of distribution is 7.5 ± 3.7 L/kg and 5.7 ± 1.8 L/kg, respectively.
      11. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:52319578-f7cc-4b87-b532-f341854e40b4 (opens source in a new tab)

        Venlafaxine label

        Version not recorded · Effective date not recorded

        Mean±SD steady-state plasma clearance of venlafaxine and ODV is 1.3±0.6 and 0.4±0.2 L/h/kg, respectively; apparent elimination half-life is 5±2 and 11±2 hours, respectively; and apparent (steady-state) volume of distribution is 7.5±3.7 and 5.7±1.8 L/kg, respectively.
      12. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:cc3a1258-aafb-48cf-86f7-fcf59e0c6cdd (opens source in a new tab)

        Venlafaxine label

        Version not recorded · Effective date not recorded

        Mean ± SD steady-state plasma clearance of venlafaxine and ODV is 1.3 ± 0.6 and 0.4 ± 0.2 L/h/kg, respectively; elimination half-life is 5 ± 2 and 11 ± 2 hours, respectively; and steady-state volume of distribution is 7.5 ± 3.7 L/kg and 5.7 ± 1.8 L/kg, respectively.
      13. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:017a84aa-0e1f-f560-e063-6294a90a9069 (opens source in a new tab)

        Venlafaxine label

        Version not recorded · Effective date not recorded

        Mean ± SD steady-state plasma clearance of venlafaxine and ODV is 1.3 ± 0.6 and 0.4 ± 0.2 L/h/kg, respectively; elimination half-life is 5 ± 2 and 11±2 hours, respectively; and steady-state volume of distribution is 7.5 ± 3.7 L/kg and 5.7 ± 1.8 L/kg, respectively.
      14. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:fda14f3f-b32c-42fe-e053-6294a90a103f (opens source in a new tab)

        Venlafaxine label

        Version not recorded · Effective date not recorded

        Mean ± SD steady-state plasma clearance of venlafaxine and ODV is 1.3 ± 0.6 and 0.4 ± 0.2 L/h/kg, respectively; elimination half-life is 5 ± 2 and 11 ± 2 hours, respectively; and steady-state volume of distribution is 7.5 ± 3.7 L/kg and 5.7 ± 1.8 L/kg, respectively.
      15. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:304bda24-9151-47b5-9f62-005ea325a11e (opens source in a new tab)

        Venlafaxine label

        Version not recorded · Effective date not recorded

        Mean ± SD steady-state plasma clearance of venlafaxine and ODV is 1.3 ± 0.6 and 0.4 ± 0.2 L/h/kg, respectively; elimination half-life is 5 ± 2 and 11 ± 2 hours, respectively; and steady-state volume of distribution is 7.5 ± 3.7 L/kg and 5.7 ± 1.8 L/kg, respectively.
      16. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:e901e476-58bd-4204-baaa-a4634ae65ab3 (opens source in a new tab)

        Venlafaxine label

        Version not recorded · Effective date not recorded

        Mean±SD steady-state plasma clearance of venlafaxine and ODV is 1.3±0.6 and 0.4±0.2 L/h/kg, respectively; apparent elimination half-life is 5±2 and 11±2 hours, respectively; and apparent (steadystate) volume of distribution is 7.5±3.7 and 5.7±1.8 L/kg, respectively.
      17. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:aaa14e95-904e-45c6-be4d-c94167b20300 (opens source in a new tab)

        Venlafaxine label

        Version not recorded · Effective date not recorded

        Mean±SD steady-state plasma clearance of venlafaxine and ODV is 1.3±0.6 and 0.4±0.2 L/h/kg, respectively; apparent elimination half-life is 5±2 and 11±2 hours, respectively; and apparent (steady-state) volume of distribution is 7.5±3.7 and 5.7±1.8 L/kg, respectively.
      18. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:7027be98-61d6-a986-c9df-60ceef5f7ff0 (opens source in a new tab)

        Venlafaxine label

        Version not recorded · Effective date not recorded

        Mean±SD steady-state plasma clearance of venlafaxine and ODV is 1.3±0.6 and 0.4±0.2 L/h/kg, respectively; apparent elimination half-life is 5±2 and 11±2 hours, respectively; and apparent (steady­ state) volume of distribution is 7.5±3.7 and 5.7±1.8 L/kg, respectively.
      19. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:b5fc0187-590c-4bb9-a910-821eb0dc1fc8 (opens source in a new tab)

        Venlafaxine label

        Version not recorded · Effective date not recorded

        Mean ± SD steady-state plasma clearance of venlafaxine and ODV is 1.3 ± 0.6 and 0.4 ± 0.2 L/h/kg, respectively; elimination half-life is 5 ± 2 and 11±2 hours, respectively; and steady-state volume of distribution is 7.5 ± 3.7 L/kg and 5.7 ± 1.8 L/kg, respectively.
      20. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:d8e00b3d-29de-1de5-e053-2995a90acb51 (opens source in a new tab)

        Venlafaxine label

        Version not recorded · Effective date not recorded

        Mean±SD steady-state plasma clearance of venlafaxine and ODV is 1.3±0.6 and 0.4±0.2 L/h/kg, respectively; apparent elimination half-life is 5±2 and 11±2 hours, respectively; and apparent (steady-state) volume of distribution is 7.5±3.7 and 5.7±1.8 L/kg, respectively.
      21. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:7bbdc9c5-a4b9-44d4-babc-46bd8c2e084a (opens source in a new tab)

        Venlafaxine label

        Version not recorded · Effective date not recorded

        Mean ± SD steady-state plasma clearance of venlafaxine and ODV is 1.3 ± 0.6 and 0.4 ± 0.2 L/h/kg, respectively; elimination half-life is 5 ± 2 and 11±2 hours, respectively; and steady-state volume of distribution is 7.5 ± 3.7 L/kg and 5.7 ± 1.8 L/kg, respectively.
      22. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:52ce8a81-d7fc-cc97-e063-6394a90a5236 (opens source in a new tab)

        Venlafaxine label

        Version not recorded · Effective date not recorded

        Mean ± SD steady-state plasma clearance of venlafaxine and ODV is 1.3 ± 0.6 and 0.4 ± 0.2 L/h/kg, respectively; elimination half-life is 5 ± 2 and 11 ± 2 hours, respectively; and steady-state volume of distribution is 7.5 ± 3.7 L/kg and 5.7 ± 1.8 L/kg, respectively.
      23. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:f56a0f70-bbb1-4e69-b969-965a72f0e2f0 (opens source in a new tab)

        Venlafaxine label

        Version not recorded · Effective date not recorded

        Mean ± SD steady-state plasma clearance of venlafaxine and ODV is 1.3 ± 0.6 and 0.4 ± 0.2 L/h/kg, respectively; elimination half-life is 5 ± 2 and 11 ± 2 hours, respectively; and steady-state volume of distribution is 7.5 ± 3.7 L/kg and 5.7 ± 1.8 L/kg, respectively.
      24. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:3eef522f-9e95-4668-bb12-09fd47ed0daf (opens source in a new tab)

        Venlafaxine label

        Version not recorded · Effective date not recorded

        Mean ± SD steady-state plasma clearance of venlafaxine and ODV is 1.3 ± 0.6 and 0.4 ± 0.2 L/h/kg, respectively; elimination half-life is 5 ± 2 and 11 ± 2 hours, respectively; and steady-state volume of distribution is 7.5 ± 3.7 L/kg and 5.7 ± 1.8 L/kg, respectively.
      25. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:d3475ce0-1368-4961-a9b9-44c5c33cdc58 (opens source in a new tab)

        Venlafaxine label

        Version not recorded · Effective date not recorded

        Mean ± SD steady-state plasma clearance of venlafaxine and ODV is 1.3 ± 0.6 and 0.4 ± 0.2 L/h/kg, respectively; elimination half-life is 5 ± 2 and 11±2 hours, respectively; and steady-state volume of distribution is 7.5 ± 3.7 L/kg and 5.7 ± 1.8 L/kg, respectively.
      26. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:5bd03cf1-e8fc-44f3-9c41-06515b897f3b (opens source in a new tab)

        Venlafaxine label

        Version not recorded · Effective date not recorded

        Mean ± SD steady-state plasma clearance of venlafaxine and ODV is 1.3 ± 0.6 and 0.4 ± 0.2 L/h/kg, respectively; elimination half-life is 5 ± 2 and 11 ± 2 hours, respectively; and steady-state volume of distribution is 7.5 ± 3.7 L/kg and 5.7 ± 1.8 L/kg, respectively.
      27. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:fa1db21b-98b8-3bde-e053-6394a90aa638 (opens source in a new tab)

        Venlafaxine label

        Version not recorded · Effective date not recorded

        Mean ± SD steady-state plasma clearance of venlafaxine and ODV is 1.3 ± 0.6 and 0.4 ± 0.2 L/h/kg, respectively; elimination half-life is 5 ± 2 and 11±2 hours, respectively; and steady-state volume of distribution is 7.5 ± 3.7 L/kg and 5.7 ± 1.8 L/kg, respectively.
      28. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:53c29dd9-a4d2-7537-e063-6294a90a290f (opens source in a new tab)

        Venlafaxine label

        Version not recorded · Effective date not recorded

        Mean ± SD steady-state plasma clearance of venlafaxine and ODV is 1.3 ± 0.6 and 0.4 ± 0.2 L/h/kg, respectively; elimination half-life is 5 ± 2 and 11 ± 2 hours, respectively; and steady-state volume of distribution is 7.5 ± 3.7 L/kg and 5.7 ± 1.8 L/kg, respectively.
      29. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:0c9511a2-c581-44cd-bf38-a751fcc658e4 (opens source in a new tab)

        Venlafaxine label

        Version not recorded · Effective date not recorded

        Mean ± SD steady-state plasma clearance of venlafaxine and ODV is 1.3 ± 0.6 and 0.4 ± 0.2 L/h/kg, respectively; elimination half-life is 5 ± 2 and 11 ± 2 hours, respectively; and steady-state volume of distribution is 7.5 ± 3.7 L/kg and 5.7 ± 1.8 L/kg, respectively.
      30. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:20319949-ccf9-477a-a6e3-53502772deb9 (opens source in a new tab)

        Venlafaxine label

        Version not recorded · Effective date not recorded

        Mean ± SD steady-state plasma clearance of venlafaxine and ODV is 1.3 ± 0.6 and 0.4 ± 0.2 L/h/kg, respectively; elimination half-life is 5 ± 2 and 11 ± 2 hours, respectively; and steady-state volume of distribution is 7.5 ± 3.7 L/kg and 5.7 ± 1.8 L/kg, respectively.
      31. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:f2b5c729-17c8-7ecc-e053-2a95a90a2e53 (opens source in a new tab)

        Venlafaxine label

        Version not recorded · Effective date not recorded

        Mean ± SD steady-state plasma clearance of venlafaxine and ODV is 1.3 ± 0.6 and 0.4 ± 0.2 L/h/kg, respectively; elimination half-life is 5 ± 2 and 11 ± 2 hours, respectively; and steady-state volume of distribution is 7.5 ± 3.7 L/kg and 5.7 ± 1.8 L/kg, respectively.
      32. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:806b3e38-3b2a-4aaa-973c-e2d921bb353e (opens source in a new tab)

        Venlafaxine label

        Version not recorded · Effective date not recorded

        Mean ± SD steady-state plasma clearance of venlafaxine and ODV is 1.3 ± 0.6 and 0.4 ± 0.2 L/h/kg, respectively; elimination half-life is 5 ± 2 and 11 ± 2 hours, respectively; and steady-state volume of distribution is 7.5 ± 3.7 L/kg and 5.7 ± 1.8 L/kg, respectively.
      33. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:c0fa9a3b-692e-2c2e-e053-2995a90aa83a (opens source in a new tab)

        Venlafaxine label

        Version not recorded · Effective date not recorded

        Mean±SD steady-state plasma clearance of venlafaxine and ODV is 1.3±0.6 and 0.4±0.2 L/h/kg, respectively; apparent elimination half-life is 5±2 and 11±2 hours, respectively; and apparent (steadystate) volume of distribution is 7.5±3.7 and 5.7±1.8 L/kg, respectively.
      34. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:ded77a84-e6d1-4471-ac6e-a05a0955daa5 (opens source in a new tab)

        Venlafaxine label

        Version not recorded · Effective date not recorded

        Mean ± SD steady-state plasma clearance of venlafaxine and ODV is 1.3 ± 0.6 and 0.4 ± 0.2 L/h/kg, respectively; elimination half-life is 5 ± 2 and 11 ± 2 hours, respectively; and steady-state volume of distribution is 7.5 ± 3.7 L/kg and 5.7 ± 1.8 L/kg, respectively.
      35. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:d8899628-6e1b-40c6-9bc8-553d91ae2d0c (opens source in a new tab)

        Venlafaxine label

        Version not recorded · Effective date not recorded

        Mean ± SD steady-state plasma clearance of venlafaxine and ODV is 1.3 ± 0.6 and 0.4 ± 0.2 L/h/kg, respectively; elimination half-life is 5 ± 2 and 11±2 hours, respectively; and steady-state volume of distribution is 7.5 ± 3.7 L/kg and 5.7 ± 1.8 L/kg, respectively.
      36. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:613658d3-7eb5-4822-961f-f4c6f6b2a2c1 (opens source in a new tab)

        Venlafaxine label

        Version not recorded · Effective date not recorded

        Mean ± SD steady-state plasma clearance of venlafaxine and ODV is 1.3 ± 0.6 and 0.4 ± 0.2 L/h/kg, respectively; apparent elimination half-life is 5 ± 2 and 11 ± 2 hours, respectively; and apparent (steady-state) volume of distribution is 7.5 ± 3.7 and 5.7 ± 1.8 L/kg, respectively.
      37. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:adeba7dd-bd15-4d8f-b703-24c3a208e740 (opens source in a new tab)

        Venlafaxine label

        Version not recorded · Effective date not recorded

        Mean ± SD steady-state plasma clearance of venlafaxine and ODV is 1.3 ± 0.6 and 0.4 ± 0.2 L/h/kg, respectively; apparent elimination half-life is 5 ± 2 and 11 ± 2 hours, respectively; and apparent (steady-state) volume of distribution is 7.5 ± 3.7 and 5.7 ± 1.8 L/kg, respectively.
      38. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:fe7de51e-8a81-fe68-e053-6294a90a7339 (opens source in a new tab)

        Venlafaxine label

        Version not recorded · Effective date not recorded

        Mean ± SD steady-state plasma clearance of venlafaxine and ODV is 1.3 ± 0.6 and 0.4 ± 0.2 L/h/kg, respectively; elimination half-life is 5 ± 2 and 11±2 hours, respectively; and steady-state volume of distribution is 7.5 ± 3.7 L/kg and 5.7 ± 1.8 L/kg, respectively.
      39. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:fb076577-b9da-c78b-e053-6394a90a107b (opens source in a new tab)

        Venlafaxine label

        Version not recorded · Effective date not recorded

        Mean ± SD steady-state plasma clearance of venlafaxine and ODV is 1.3 ± 0.6 and 0.4 ± 0.2 L/h/kg, respectively; elimination half-life is 5 ± 2 and 11 ± 2 hours, respectively; and steady-state volume of distribution is 7.5 ± 3.7 L/kg and 5.7 ± 1.8 L/kg, respectively.
      40. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:db5f1693-ca64-7a97-e053-2995a90acbff (opens source in a new tab)

        Venlafaxine label

        Version not recorded · Effective date not recorded

        Mean ± SD steady-state plasma clearance of venlafaxine and ODV is 1.3 ± 0.6 and 0.4 ± 0.2 L/h/kg, respectively; elimination half-life is 5 ± 2 and 11 ± 2 hours, respectively; and steady-state volume of distribution is 7.5 ± 3.7 L/kg and 5.7 ± 1.8 L/kg, respectively.
      41. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:ddb51556-0292-4aa9-b781-a402c912591f (opens source in a new tab)

        Venlafaxine label

        Version not recorded · Effective date not recorded

        Mean ± SD steady-state plasma clearance of venlafaxine and ODV is 1.3 ± 0.6 and 0.4 ± 0.2 L/h/kg, respectively; elimination half-life is 5 ± 2 and 11 ± 2 hours, respectively; and steady-state volume of distribution is 7.5 ± 3.7 L/kg and 5.7 ± 1.8 L/kg, respectively.
      42. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:37aaa8ac-4e0c-4e04-98b5-19b0d90d857c (opens source in a new tab)

        Venlafaxine label

        Version not recorded · Effective date not recorded

        Mean ± SD steady-state plasma clearance of venlafaxine and ODV is 1.3 ± 0.6 and 0.4 ± 0.2 L/h/kg, respectively; elimination half-life is 5 ± 2 and 11 ± 2 hours, respectively; and steady-state volume of distribution is 7.5 ± 3.7 L/kg and 5.7 ± 1.8 L/kg, respectively.
      43. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:53e5c5a2-b8e7-3d75-e063-6294a90a508b (opens source in a new tab)

        Venlafaxine label

        Version not recorded · Effective date not recorded

        Mean ± SD steady-state plasma clearance of venlafaxine and ODV is 1.3 ± 0.6 and 0.4 ± 0.2 L/h/kg, respectively; elimination half-life is 5 ± 2 and 11 ± 2 hours, respectively; and steady-state volume of distribution is 7.5 ± 3.7 L/kg and 5.7 ± 1.8 L/kg, respectively.
      44. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:4a82cef5-693e-46e9-90c4-bff753cdce37 (opens source in a new tab)

        Venlafaxine label

        Version not recorded · Effective date not recorded

        Mean ± SD steady-state plasma clearance of venlafaxine and ODV is 1.3 ± 0.6 and 0.4 ± 0.2 L/h/kg, respectively; elimination half-life is 5 ± 2 and 11 ± 2 hours, respectively; and steady-state volume of distribution is 7.5 ± 3.7 L/kg and 5.7 ± 1.8 L/kg, respectively.
      45. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:b23637e5-d37f-41b5-ba76-fc053e903bc2 (opens source in a new tab)

        Venlafaxine label

        Version not recorded · Effective date not recorded

        Mean ± SD steady-state plasma clearance of venlafaxine and ODV is 1.3 ± 0.6 and 0.4 ± 0.2 L/h/kg, respectively; elimination half-life is 5 ± 2 and 11 ± 2 hours, respectively; and steady-state volume of distribution is 7.5 ± 3.7 L/kg and 5.7 ± 1.8 L/kg, respectively.
      46. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:172b3d3d-bdae-47bf-8fba-edd6da1a8649 (opens source in a new tab)

        Venlafaxine label

        Version not recorded · Effective date not recorded

        Mean ± SD steady-state plasma clearance of venlafaxine and ODV is 1.3 ± 0.6 and 0.4 ± 0.2 L/h/kg, respectively; elimination half-life is 5 ± 2 and 11±2 hours, respectively; and steady-state volume of distribution is 7.5 ± 3.7 L/kg and 5.7 ± 1.8 L/kg, respectively.
      47. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:18e77a42-6552-4042-9ed3-046c94f4f921 (opens source in a new tab)

        Venlafaxine label

        Version not recorded · Effective date not recorded

        Mean±SD steady-state plasma clearance of venlafaxine and ODV is 1.3±0.6 and 0.4±0.2 L/h/kg, respectively; apparent elimination half-life is 5±2 and 11±2 hours, respectively; and apparent (steady-state) volume of distribution is 7.5±3.7 and 5.7±1.8 L/kg, respectively.
      48. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:922388b3-fc1c-46c6-b314-9049bd042df7 (opens source in a new tab)

        Venlafaxine label

        Version not recorded · Effective date not recorded

        Mean±SD steady-state plasma clearance of venlafaxine and ODV is 1.3±0.6 and 0.4±0.2 L/h/kg, respectively; apparent elimination half-life is 5±2 and 11±2 hours, respectively; and apparent (steady-state) volume of distribution is 7.5±3.7 and 5.7±1.8 L/kg, respectively.
      49. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:185d90ab-1ba4-dd59-0565-e35f0fd39a2d (opens source in a new tab)

        Venlafaxine label

        Version not recorded · Effective date not recorded

        Mean ± SD steady-state plasma clearance of venlafaxine and ODV is 1.3 ± 0.6 and 0.4 ± 0.2 L/h/kg, respectively; elimination half-life is 5 ± 2 and 11±2 hours, respectively; and steady-state volume of distribution is 7.5 ± 3.7 L/kg and 5.7 ± 1.8 L/kg, respectively.
      50. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:70d47b50-5722-3868-e053-2991aa0af85e (opens source in a new tab)

        Venlafaxine label

        Version not recorded · Effective date not recorded

        Mean ± SD steady-state plasma clearance of venlafaxine and ODV is 1.3 ± 0.6 and 0.4 ± 0.2 L/h/kg, respectively; elimination half-life is 5 ± 2 and 11 ± 2 hours, respectively; and steady-state volume of distribution is 7.5 ± 3.7 L/kg and 5.7 ± 1.8 L/kg, respectively.
      51. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:106d0d7b-925b-74e7-83cb-562144ce1f92 (opens source in a new tab)

        Venlafaxine label

        Version not recorded · Effective date not recorded

        Mean ± SD steady-state plasma clearance of venlafaxine and ODV is 1.3 ± 0.6 and 0.4 ± 0.2 L/h/kg, respectively; elimination half-life is 5 ± 2 and 11 ± 2 hours, respectively; and steady-state volume of distribution is 7.5 ± 3.7 L/kg and 5.7 ± 1.8 L/kg, respectively.
      52. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:49e5833b-4693-45b5-9abb-1b369eb4086d (opens source in a new tab)

        Venlafaxine label

        Version not recorded · Effective date not recorded

        Mean ± SD steady-state plasma clearance of venlafaxine and ODV is 1.3 ± 0.6 and 0.4 ± 0.2 L/h/kg, respectively; elimination half-life is 5 ± 2 and 11 ± 2 hours, respectively; and steady-state volume of distribution is 7.5 ± 3.7 L/kg and 5.7 ± 1.8 L/kg, respectively.
      53. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:8f9d3d30-e9a6-6c85-e053-2a95a90a5524 (opens source in a new tab)

        Venlafaxine label

        Version not recorded · Effective date not recorded

        Mean±SD steady-state plasma clearance of venlafaxine and ODV is 1.3±0.6 and 0.4±0.2 L/h/kg, respectively; apparent elimination half-life is 5±2 and 11±2 hours, respectively; and apparent (steady-state) volume of distribution is 7.5±3.7 and 5.7±1.8 L/kg, respectively.
      54. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:9d38eac0-9d64-1274-e053-2995a90a189a (opens source in a new tab)

        Venlafaxine label

        Version not recorded · Effective date not recorded

        Mean±SD steady-state plasma clearance of venlafaxine and ODV is 1.3±0.6 and 0.4±0.2 L/h/kg, respectively; apparent elimination half-life is 5±2 and 11±2 hours, respectively; and apparent (steady-state) volume of distribution is 7.5±3.7 and 5.7±1.8 L/kg, respectively.
      55. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:e14bfb9f-3bd2-4419-9294-9c286e79730a (opens source in a new tab)

        Venlafaxine label

        Version not recorded · Effective date not recorded

        Mean ± SD steady-state plasma clearance of venlafaxine and ODV is 1.3 ± 0.6 and 0.4 ± 0.2 L/h/kg, respectively; elimination half-life is 5 ± 2 and 11 ± 2 hours, respectively; and steady-state volume of distribution is 7.5 ± 3.7 L/kg and 5.7 ± 1.8 L/kg, respectively.
      56. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:dabfa0f2-0060-f0ee-e053-2a95a90aec9b (opens source in a new tab)

        Venlafaxine label

        Version not recorded · Effective date not recorded

        Mean ± SD steady-state plasma clearance of venlafaxine and ODV is 1.3 ± 0.6 and 0.4 ± 0.2 L/h/kg, respectively; elimination half-life is 5 ± 2 and 11 ± 2 hours, respectively; and steady-state volume of distribution is 7.5 ± 3.7 L/kg and 5.7 ± 1.8 L/kg, respectively.
      57. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:fab65158-b2f7-1db7-e053-6294a90af231 (opens source in a new tab)

        Venlafaxine label

        Version not recorded · Effective date not recorded

        Mean ± SD steady-state plasma clearance of venlafaxine and ODV is 1.3 ± 0.6 and 0.4 ± 0.2 L/h/kg, respectively; elimination half-life is 5 ± 2 and 11±2 hours, respectively; and steady-state volume of distribution is 7.5 ± 3.7 L/kg and 5.7 ± 1.8 L/kg, respectively.
      58. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:c2a3283f-ba30-f506-e053-2995a90a9378 (opens source in a new tab)

        Venlafaxine label

        Version not recorded · Effective date not recorded

        Mean ± SD steady-state plasma clearance of venlafaxine and ODV is 1.3 ± 0.6 and 0.4 ± 0.2 L/h/kg, respectively; elimination half-life is 5 ± 2 and 11 ± 2 hours, respectively; and steady-state volume of distribution is 7.5 ± 3.7 L/kg and 5.7 ± 1.8 L/kg, respectively.
      59. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:55889b3d-74c9-4638-9a14-6a4ca3a99f7f (opens source in a new tab)

        Venlafaxine label

        Version not recorded · Effective date not recorded

        Mean ± SD steady-state plasma clearance of venlafaxine and ODV is 1.3 ± 0.6 and 0.4 ± 0.2 L/h/kg, respectively; elimination half-life is 5 ± 2 and 11 ± 2 hours, respectively; and steady-state volume of distribution is 7.5 ± 3.7 L/kg and 5.7 ± 1.8 L/kg, respectively.
      60. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:b73da6e2-1494-436f-a204-2e4e4c5974b6 (opens source in a new tab)

        Venlafaxine label

        Version not recorded · Effective date not recorded

        Mean ± SD steady-state plasma clearance of venlafaxine and ODV is 1.3 ± 0.6 and 0.4 ± 0.2 L/h/kg, respectively; elimination half-life is 5 ± 2 and 11 ± 2 hours, respectively; and steady-state volume of distribution is 7.5 ± 3.7 L/kg and 5.7 ± 1.8 L/kg, respectively.
      61. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:67b323a7-a8c9-410f-bff0-0e515bef41a7 (opens source in a new tab)

        Venlafaxine label

        Version not recorded · Effective date not recorded

        Mean ± SD steady-state plasma clearance of venlafaxine and ODV is 1.3 ± 0.6 and 0.4 ± 0.2 L/h/kg, respectively; elimination half-life is 5 ± 2 and 11 ± 2 hours, respectively; and steady-state volume of distribution is 7.5 ± 3.7 L/kg and 5.7 ± 1.8 L/kg, respectively.
      62. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:df7e0982-3eb0-4bdf-8f7f-4f4a48476ed7 (opens source in a new tab)

        Venlafaxine label

        Version not recorded · Effective date not recorded

        Mean±SD steady-state plasma clearance of venlafaxine and ODV is 1.3±0.6 and 0.4±0.2 L/h/kg, respectively; apparent elimination half-life is 5±2 and 11±2 hours, respectively; and apparent (steady-state) volume of distribution is 7.5±3.7 and 5.7±1.8 L/kg, respectively.
      63. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:1471508e-7fe4-43db-94ea-b4df1bcbafa9 (opens source in a new tab)

        Venlafaxine label

        Version not recorded · Effective date not recorded

        Mean ± SD steady-state plasma clearance of venlafaxine and ODV is 1.3 ± 0.6 and 0.4 ± 0.2 L/h/kg, respectively; elimination half-life is 5 ± 2 and 11±2 hours, respectively; and steady-state volume of distribution is 7.5 ± 3.7 L/kg and 5.7 ± 1.8 L/kg, respectively.
      64. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:6cb943a8-5972-292f-e053-2991aa0ae3ee (opens source in a new tab)

        Venlafaxine label

        Version not recorded · Effective date not recorded

        Mean±SD steady-state plasma clearance of venlafaxine and ODV is 1.3±0.6 and 0.4±0.2 L/h/kg, respectively; apparent elimination half-life is 5±2 and 11±2 hours, respectively; and apparent (steady state) volume of distribution is 7.5±3.7 and 5.7±1.8 L/kg, respectively.
      65. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:ab58f3ef-1fd3-4c68-861f-20d8fdd1b433 (opens source in a new tab)

        Venlafaxine label

        Version not recorded · Effective date not recorded

        Mean ± SD steady-state plasma clearance of venlafaxine and ODV is 1.3 ± 0.6 and 0.4 ± 0.2 L/h/kg, respectively; elimination half-life is 5 ± 2 and 11 ± 2 hours, respectively; and steady-state volume of distribution is 7.5 ± 3.7 L/kg and 5.7 ± 1.8 L/kg, respectively.
      66. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:f7a9741b-2dd3-d8f3-e053-6294a90a4d73 (opens source in a new tab)

        Venlafaxine label

        Version not recorded · Effective date not recorded

        Mean±SD steady-state plasma clearance of venlafaxine and ODV is 1.3±0.6 and 0.4±0.2 L/h/kg, respectively; apparent elimination half-life is 5±2 and 11±2 hours, respectively; and apparent (steady-state) volume of distribution is 7.5±3.7 and 5.7±1.8 L/kg, respectively.
      67. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:d4638a83-2720-430c-b529-c852aa2f7366 (opens source in a new tab)

        Venlafaxine label

        Version not recorded · Effective date not recorded

        Mean ± SD steady-state plasma clearance of venlafaxine and ODV is 1.3 ± 0.6 and 0.4 ± 0.2 L/h/kg, respectively; elimination half-life is 5 ± 2 and 11±2 hours, respectively; and steady-state volume of distribution is 7.5 ± 3.7 L/kg and 5.7 ± 1.8 L/kg, respectively.
      68. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:18495527-add4-42a5-bbf7-9f8dc2df06af (opens source in a new tab)

        Venlafaxine label

        Version not recorded · Effective date not recorded

        Mean ± SD steady-state plasma clearance of venlafaxine and ODV is 1.3 ± 0.6 and 0.4 ± 0.2 L/h/kg, respectively; elimination half-life is 5 ± 2 and 11 ± 2 hours, respectively; and steady-state volume of distribution is 7.5 ± 3.7 L/kg and 5.7 ± 1.8 L/kg, respectively.
      69. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:80ac757d-c629-4579-8afd-cae0ee9cd614 (opens source in a new tab)

        Venlafaxine label

        Version not recorded · Effective date not recorded

        Mean ± SD steady-state plasma clearance of venlafaxine and ODV is 1.3 ± 0.6 and 0.4 ± 0.2 L/h/kg, respectively; elimination half-life is 5 ± 2 and 11 ± 2 hours, respectively; and steady-state volume of distribution is 7.5 ± 3.7 L/kg and 5.7 ± 1.8 L/kg, respectively.

    3. 2 hours

      Numeric value
      2
      Unit
      hours
      Source records
      1

      Population and context: Unknown: population and formulation context were not structurally extracted from this source sentence.

      Show all 1 source records
      1. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:7f224c88-9425-9ef0-01bc-dcf3bdafbd89 (opens source in a new tab)

        Venlafaxine label

        Version not recorded · Effective date not recorded

        Mean SD steady-state plasma clearance of venlafaxine and ODV is 1.3 0.6 and 0.4 0.2 L/h/kg, respectively; apparent elimination half-life is 5 2 and 11 2 hours, respectively; and apparent (steady state) volume of distribution is 7.5 3.7 and 5.7 1.8 L/kg, respectively.

    4. 6.8 ± 1.6 hours

      Numeric value
      6.8
      Unit
      hours
      Source records
      1

      Population and context: Unknown: population and formulation context were not structurally extracted from this source sentence.

      Show all 1 source records
      1. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:e81a2daf-b8b2-7c05-b532-bc775700b100 (opens source in a new tab)

        Venlafaxine label

        Version not recorded · Effective date not recorded

        Elimination Following a single 112.5 mg dose of Venlafaxine Extended-Release Tablets, the mean apparent clearance (CL/F) of venlafaxine is 170 L/hour and the mean elimination half-life (t 1/2 ) of venlafaxine and ODV are 6.8 ± 1.6 hours and 11.3 ± 2.3 hours, respectively.

  2. Projected row 1622

    Medicine slug
    venlafaxine
    Compared field
    tMax
    Comparison state
    insufficient_context
    Reason codes
    • STRUCTURED_CONTEXT_MISSING
    Documents examined
    178
    Source count
    22
    Agreement rate
    0.863636
    Recorded readings

    1. 6.3 ± 2.3 hours

      Numeric value
      6.3
      Unit
      hours
      Source records
      19

      Population and context: Unknown: population and formulation context were not structurally extracted from this source sentence.

      Show all 19 source records
      1. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:68f40801-d35e-464e-ac94-21016b617ea2 (opens source in a new tab)

        Venlafaxine label

        Version not recorded · Effective date not recorded

        T max was 6.3 ± 2.3 hours.
      2. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:5efe1336-c796-4560-8110-a64c80eefb0c (opens source in a new tab)

        Venlafaxine label

        Version not recorded · Effective date not recorded

        T max was 6.3 ± 2.3 hours.
      3. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:edefc932-d25d-4ead-b348-b3b6d9232091 (opens source in a new tab)

        Venlafaxine label

        Version not recorded · Effective date not recorded

        T max was 6.3 ± 2.3 hours.
      4. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:14b38374-7287-47dd-8ef9-e88bd5b23a26 (opens source in a new tab)

        Venlafaxine label

        Version not recorded · Effective date not recorded

        T max was 6.3 ± 2.3 hours.
      5. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:2cf6e6ad-7d00-0db1-e063-6394a90ab1ec (opens source in a new tab)

        Venlafaxine label

        Version not recorded · Effective date not recorded

        T max was 6.3 ± 2.3 hours.
      6. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:1ce5786e-22e6-4afa-8052-6eababc6aa4e (opens source in a new tab)

        Venlafaxine label

        Version not recorded · Effective date not recorded

        T max was 6.3 ± 2.3 hours.
      7. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:9312f4df-63d9-4167-880f-36a816870442 (opens source in a new tab)

        Venlafaxine label

        Version not recorded · Effective date not recorded

        T max was 6.3 ± 2.3 hours.
      8. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:22d4817c-1f19-4490-8a38-d8904f0374f7 (opens source in a new tab)

        Venlafaxine label

        Version not recorded · Effective date not recorded

        T max was 6.3 ± 2.3 hours.
      9. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:8c4ccc5c-f6a2-4ce3-8866-9e6b32b08fd3 (opens source in a new tab)

        Venlafaxine label

        Version not recorded · Effective date not recorded

        T max was 6.3 ± 2.3 hours.
      10. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:4b23e4bd-b6ab-42f2-b389-0be0b7e11b92 (opens source in a new tab)

        Venlafaxine label

        Version not recorded · Effective date not recorded

        T max was 6.3 ± 2.3 hours.
      11. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:fdaed1c2-dd0a-4bf3-975a-86fe3e7f0c97 (opens source in a new tab)

        Venlafaxine label

        Version not recorded · Effective date not recorded

        T max was 6.3 ± 2.3 hours.
      12. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:516e7566-35c2-4a25-88d8-54d9dbc8f6be (opens source in a new tab)

        Venlafaxine label

        Version not recorded · Effective date not recorded

        T max was 6.3 ± 2.3 hours.
      13. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:074f4478-e81b-45a2-ae85-ffd27bed940f (opens source in a new tab)

        Venlafaxine label

        Version not recorded · Effective date not recorded

        T max was 6.3 ± 2.3 hours.
      14. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:349308ef-2caf-4fec-b428-56ae06c6771d (opens source in a new tab)

        Venlafaxine label

        Version not recorded · Effective date not recorded

        T max was 6.3 ± 2.3 hours.
      15. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:85ec2d3f-49e4-4ac5-bd4a-c227589dbf58 (opens source in a new tab)

        Venlafaxine label

        Version not recorded · Effective date not recorded

        T max was 6.3 ± 2.3 hours.
      16. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:45cb4c19-fbf4-4ff5-af6f-b25a31ebc1e1 (opens source in a new tab)

        Venlafaxine label

        Version not recorded · Effective date not recorded

        T max was 6.3 ± 2.3 hours.
      17. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:dc989aa7-c4ab-4359-a971-523eb477ef9b (opens source in a new tab)

        Venlafaxine label

        Version not recorded · Effective date not recorded

        T max was 6.3 ± 2.3 hours.
      18. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:528d5392-4ad5-48c5-963d-6ebfb9187db4 (opens source in a new tab)

        Venlafaxine label

        Version not recorded · Effective date not recorded

        T max was 6.3 ± 2.3 hours.
      19. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:9df3a51c-1b89-4d2a-8f41-3755910e9bfb (opens source in a new tab)

        Venlafaxine label

        Version not recorded · Effective date not recorded

        T max was 6.3 ± 2.3 hours.

    2. 6.3 hours

      Numeric value
      6.3
      Unit
      hours
      Source records
      2

      Population and context: Unknown: population and formulation context were not structurally extracted from this source sentence.

      Show all 2 source records
      1. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:db1d16b3-d1a2-4f41-adff-a87c17689aa0 (opens source in a new tab)

        Venlafaxine label

        Version not recorded · Effective date not recorded

        T max was 6.3 hours ± 2.3 hours.
      2. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:570beece-6f30-4850-a3bc-636e7cf8d423 (opens source in a new tab)

        Venlafaxine label

        Version not recorded · Effective date not recorded

        T max was 6.3 hours ± 2.3 hours.

    3. 10 hours

      Numeric value
      10
      Unit
      hours
      Source records
      1

      Population and context: Unknown: population and formulation context were not structurally extracted from this source sentence.

      Show all 1 source records
      1. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:e81a2daf-b8b2-7c05-b532-bc775700b100 (opens source in a new tab)

        Venlafaxine label

        Version not recorded · Effective date not recorded

        Following a 112.5 mg Venlafaxine Extended-Release Tablets under fed conditions, the median time to attain C max (T max ) was 10 hours (range 5-18 hours) for venlafaxine and 18 hours (range 5-28 hours) for ODV.

  3. Projected row 1623

    Medicine slug
    venlafaxine
    Compared field
    volumeOfDistribution
    Comparison state
    not_comparable
    Reason codes
    • DENOMINATOR_MISMATCH
    Documents examined
    178
    Source count
    138
    Agreement rate
    0.992754
    Recorded readings

    1. 7.5 ± 3.7 L/kg

      Numeric value
      7.5
      Unit
      L/kg
      Source records
      137

      Population and context: Unknown: population and formulation context were not structurally extracted from this source sentence.

      Show all 137 source records
      1. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:33068acd-d361-4cd9-b994-02a7865ff04f (opens source in a new tab)

        Venlafaxine label

        Version not recorded · Effective date not recorded

        The apparent volume of distribution at steady-state is 7.5 ± 3.7 L/kg for venlafaxine and 5.7 ± 1.8 L/kg for ODV.
      2. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:ea5914ab-28f3-4cb3-bade-6eaccac214e4 (opens source in a new tab)

        Venlafaxine label

        Version not recorded · Effective date not recorded

        The apparent volume of distribution at steady-state is 7.5±3.7 L/kg for venlafaxine and 5.7±1.8 L/kg for ODV.
      3. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:b19ec628-4034-4316-ad3d-46c1ee220728 (opens source in a new tab)

        Venlafaxine label

        Version not recorded · Effective date not recorded

        Mean ± SD steady-state plasma clearance of venlafaxine and ODV is 1.3 ± 0.6 and 0.4 ± 0.2 L/h/kg, respectively; elimination half-life is 5 ± 2 and 11 ± 2 hours, respectively; and steady-state volume of distribution is 7.5 ± 3.7 L/kg and 5.7 ± 1.8 L/kg, respectively.
      4. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:9c061460-3b80-41e1-a87a-1a25108ff740 (opens source in a new tab)

        Venlafaxine label

        Version not recorded · Effective date not recorded

        The apparent volume of distribution at steady-state is 7.5 ± 3.7 L/kg for venlafaxine and 5.7 ± 1.8 L/kg for ODV.
      5. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:1ce9121b-aaa0-a5bb-e063-6394a90a2f3c (opens source in a new tab)

        Venlafaxine label

        Version not recorded · Effective date not recorded

        Mean ± SD steady-state plasma clearance of venlafaxine and ODV is 1.3 ± 0.6 and 0.4 ± 0.2 L/h/kg, respectively; elimination half-life is 5 ± 2 and 11 ± 2 hours, respectively; and steady-state volume of distribution is 7.5 ± 3.7 L/kg and 5.7 ± 1.8 L/kg, respectively.
      6. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:470ad045-6c82-4e44-8e88-0e2b01a41ff2 (opens source in a new tab)

        Venlafaxine label

        Version not recorded · Effective date not recorded

        Mean ± SD steady-state plasma clearance of venlafaxine and ODV is 1.3 ± 0.6 and 0.4 ± 0.2 L/h/kg, respectively; elimination half-life is 5 ± 2 and 11 ± 2 hours, respectively; and steady-state volume of distribution is 7.5 ± 3.7 L/kg and 5.7 ± 1.8 L/kg, respectively.
      7. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:f8fd4381-52f2-d9c1-e053-6394a90a08e5 (opens source in a new tab)

        Venlafaxine label

        Version not recorded · Effective date not recorded

        The apparent volume of distribution at steady-state is 7.5 ± 3.7 L/kg for venlafaxine and 5.7 ± 1.8 L/kg for ODV.
      8. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:15c77ad7-7edc-4c36-ba3f-3ef05dfb12dc (opens source in a new tab)

        Venlafaxine label

        Version not recorded · Effective date not recorded

        The apparent volume of distribution at steady-state is 7.5 ± 3.7 L/kg for venlafaxine and 5.7 ± 1.8 L/kg for ODV.
      9. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:5c943206-6df8-4fc5-ab1d-d34b9715182c (opens source in a new tab)

        Venlafaxine label

        Version not recorded · Effective date not recorded

        The apparent volume of distribution at steady-state is 7.5 ± 3.7 L/kg for venlafaxine and 5.7 ± 1.8 L/kg for ODV.
      10. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:ac9b972d-8b8a-4727-90c2-b208f91272fd (opens source in a new tab)

        Venlafaxine label

        Version not recorded · Effective date not recorded

        The apparent volume of distribution at steady-state is 7.5 ± 3.7 L/kg for venlafaxine and 5.7 ± 1.8 L/kg for ODV.
      11. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:0a1b6bcd-8d46-44ab-bc5d-65515601d2ff (opens source in a new tab)

        Venlafaxine label

        Version not recorded · Effective date not recorded

        The apparent volume of distribution at steady-state is 7.5±3.7 L/kg for venlafaxine and 5.7±1.8 L/kg for ODV.
      12. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:72efad5f-0909-46a5-aa13-ac24fe015fe6 (opens source in a new tab)

        Venlafaxine label

        Version not recorded · Effective date not recorded

        Mean ± SD steady-state plasma clearance of venlafaxine and ODV is 1.3 ± 0.6 and 0.4 ± 0.2 L/h/kg, respectively; elimination half-life is 5 ± 2 and 11±2 hours, respectively; and steady-state volume of distribution is 7.5 ± 3.7 L/kg and 5.7 ± 1.8 L/kg, respectively.
      13. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:2887a463-2da1-4f8d-afef-f4c88d31e04d (opens source in a new tab)

        Venlafaxine label

        Version not recorded · Effective date not recorded

        Mean ± SD steady-state plasma clearance of venlafaxine and ODV is 1.3 ± 0.6 and 0.4 ± 0.2 L/h/kg, respectively; elimination half-life is 5 ± 2 and 11 ± 2 hours, respectively; and steady-state volume of distribution is 7.5 ± 3.7 L/kg and 5.7 ± 1.8 L/kg, respectively.
      14. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:8d6e699b-24bf-4e77-8a7f-acd496a700c7 (opens source in a new tab)

        Venlafaxine label

        Version not recorded · Effective date not recorded

        The apparent volume of distribution at steady-state is 7.5 ± 3.7 L/kg for venlafaxine and 5.7 ± 1.8 L/kg for ODV.
      15. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:e1114c1d-c193-4c0c-ad1c-c17b3fc61723 (opens source in a new tab)

        Venlafaxine label

        Version not recorded · Effective date not recorded

        The apparent volume of distribution at steady-state is 7.5 ± 3.7 L/kg for venlafaxine and 5.7 ± 1.8 L/kg for ODV.
      16. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:0ee91447-2c23-4519-81cc-550b5416dd6b (opens source in a new tab)

        Venlafaxine label

        Version not recorded · Effective date not recorded

        The apparent volume of distribution at steady-state is 7.5 ± 3.7 L/kg for venlafaxine and 5.7 ± 1.8 L/kg for ODV.
      17. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:c4312b7b-7a42-45f1-b6e6-e20ea76020c4 (opens source in a new tab)

        Venlafaxine label

        Version not recorded · Effective date not recorded

        The apparent volume of distribution at steady-state is 7.5 ± 3.7 L/kg for venlafaxine and 5.7 ± 1.8 L/kg for ODV.
      18. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:4a007068-89d9-c296-e063-6394a90ad6d0 (opens source in a new tab)

        Venlafaxine label

        Version not recorded · Effective date not recorded

        The apparent volume of distribution at steady-state is 7.5 ± 3.7 L/kg for venlafaxine and 5.7 ± 1.8 L/kg for ODV.
      19. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:d7d1319c-500e-4ca0-83a1-a739cfa01cf7 (opens source in a new tab)

        Venlafaxine label

        Version not recorded · Effective date not recorded

        The apparent volume of distribution at steady-state is 7.5±3.7 L/kg for venlafaxine and 5.7±1.8 L/kg for ODV.
      20. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:7852be9e-0c1d-47a8-9513-c3a04b365763 (opens source in a new tab)

        Venlafaxine label

        Version not recorded · Effective date not recorded

        The apparent volume of distribution at steady-state is 7.5 ± 3.7 L/kg for venlafaxine and 5.7 ± 1.8 L/kg for ODV.
      21. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:5359012e-a868-3aa3-e063-6294a90a74e2 (opens source in a new tab)

        Venlafaxine label

        Version not recorded · Effective date not recorded

        The apparent volume of distribution at steady-state is 7.5 ± 3.7 L/kg for venlafaxine and 5.7 ± 1.8 L/kg for ODV.
      22. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:b865c175-e75d-4cb4-ac29-dec72226302c (opens source in a new tab)

        Venlafaxine label

        Version not recorded · Effective date not recorded

        The apparent volume of distribution at steady-state is 7.5 ± 3.7 L/kg for venlafaxine and 5.7 ± 1.8 L/kg for ODV.
      23. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:430777f0-347c-4f21-8c5d-55f4e9897e74 (opens source in a new tab)

        Venlafaxine label

        Version not recorded · Effective date not recorded

        The apparent volume of distribution at steady-state is 7.5±3.7 L/kg for venlafaxine and 5.7±1.8 L/kg for ODV.
      24. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:c69d16fd-b82d-4708-aece-ab4f60b29cc6 (opens source in a new tab)

        Venlafaxine label

        Version not recorded · Effective date not recorded

        The apparent volume of distribution at steady-state is 7.5 ± 3.7 L/kg for venlafaxine and 5.7 ± 1.8 L/kg for ODV.
      25. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:38fd2c97-cd30-2f7d-e054-00144ff8d46c (opens source in a new tab)

        Venlafaxine label

        Version not recorded · Effective date not recorded

        Mean ± SD steady-state plasma clearance of venlafaxine and ODV is 1.3 ± 0.6 and 0.4 ± 0.2 L/h/kg, respectively; elimination half-life is 5 ± 2 and 11 ± 2 hours, respectively; and steady-state volume of distribution is 7.5 ± 3.7 L/kg and 5.7 ± 1.8 L/kg, respectively.
      26. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:963e5599-f9af-45c2-8cf4-13cf52eed6a0 (opens source in a new tab)

        Venlafaxine label

        Version not recorded · Effective date not recorded

        The apparent volume of distribution at steady-state is 7.5±3.7 L/kg for venlafaxine and 5.7±1.8 L/kg for ODV.
      27. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:2ed61dcf-42e3-47cf-a607-459eef5fea98 (opens source in a new tab)

        Venlafaxine label

        Version not recorded · Effective date not recorded

        Mean ± SD steady-state plasma clearance of venlafaxine and ODV is 1.3 ± 0.6 and 0.4 ± 0.2 L/h/kg, respectively; elimination half-life is 5 ± 2 and 11 ± 2 hours, respectively; and steady-state volume of distribution is 7.5 ± 3.7 L/kg and 5.7 ± 1.8 L/kg, respectively.
      28. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:cc3a1258-aafb-48cf-86f7-fcf59e0c6cdd (opens source in a new tab)

        Venlafaxine label

        Version not recorded · Effective date not recorded

        Mean ± SD steady-state plasma clearance of venlafaxine and ODV is 1.3 ± 0.6 and 0.4 ± 0.2 L/h/kg, respectively; elimination half-life is 5 ± 2 and 11 ± 2 hours, respectively; and steady-state volume of distribution is 7.5 ± 3.7 L/kg and 5.7 ± 1.8 L/kg, respectively.
      29. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:1e1119f7-0c2e-4587-a24d-0066f73b2e65 (opens source in a new tab)

        Venlafaxine label

        Version not recorded · Effective date not recorded

        The apparent volume of distribution at steady-state is 7.5 ± 3.7 L/kg for venlafaxine and 5.7 ± 1.8 L/kg for ODV.
      30. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:baae24d6-e425-4cfc-9a53-3cd223b6d344 (opens source in a new tab)

        Venlafaxine label

        Version not recorded · Effective date not recorded

        The apparent volume of distribution at steady-state is 7.5 ± 3.7 L/kg for venlafaxine and 5.7 ± 1.8 L/kg for ODV.
      31. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:2c2bb0e6-5a73-ff57-e063-6294a90a88d3 (opens source in a new tab)

        Venlafaxine label

        Version not recorded · Effective date not recorded

        The apparent volume of distribution at steady-state is 7.5 ± 3.7 L/kg for venlafaxine and 5.7 ± 1.8 L/kg for ODV.
      32. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:5351fe67-17d9-42ec-9e8b-6585fdb9e29e (opens source in a new tab)

        Venlafaxine label

        Version not recorded · Effective date not recorded

        The apparent volume of distribution at steady-state is 7.5 ± 3.7 L/kg for venlafaxine and 5.7 ± 1.8 L/kg for ODV.
      33. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:33b39416-7981-46fb-ba31-e933a6afcf8b (opens source in a new tab)

        Venlafaxine label

        Version not recorded · Effective date not recorded

        The apparent volume of distribution at steady-state is 7.5±3.7 L/kg for venlafaxine and 5.7±1.8 L/kg for ODV.
      34. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:92b3f73d-d6ca-4d7d-9035-5700f527cb85 (opens source in a new tab)

        Venlafaxine label

        Version not recorded · Effective date not recorded

        The apparent volume of distribution at steady-state is 7.5±3.7 L/kg for venlafaxine and 5.7±1.8 L/kg for ODV.
      35. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:9fda0f8d-b24e-4581-9dca-7aaaf86e2413 (opens source in a new tab)

        Venlafaxine label

        Version not recorded · Effective date not recorded

        The apparent volume of distribution at steady-state is 7.5 ± 3.7 L/kg for venlafaxine and 5.7 ± 1.8 L/kg for ODV.
      36. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:4992698e-5d5a-6468-e063-6394a90ab404 (opens source in a new tab)

        Venlafaxine label

        Version not recorded · Effective date not recorded

        The apparent volume of distribution at steady-state is 7.5 ± 3.7 L/kg for venlafaxine and 5.7 ± 1.8 L/kg for ODV.
      37. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:812ca864-8230-4c84-a7f4-d1b926dee31a (opens source in a new tab)

        Venlafaxine label

        Version not recorded · Effective date not recorded

        The apparent volume of distribution at steady-state is 7.5 ± 3.7 L/kg for venlafaxine and 5.7 ± 1.8 L/kg for ODV.
      38. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:7fcd7995-81fb-4368-bd4c-3726b2ae363e (opens source in a new tab)

        Venlafaxine label

        Version not recorded · Effective date not recorded

        The apparent volume of distribution at steady-state is 7.5±3.7 L/kg for venlafaxine and 5.7±1.8 L/kg for ODV.
      39. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:c37a73fa-ceee-4555-a61b-e1e66ad6e97d (opens source in a new tab)

        Venlafaxine label

        Version not recorded · Effective date not recorded

        The apparent volume of distribution at steady-state is 7.5±3.7 L/kg for venlafaxine and 5.7±1.8 L/kg for ODV.
      40. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:4e3053b9-cdec-4f4d-85ae-2e55cf1cc185 (opens source in a new tab)

        Venlafaxine label

        Version not recorded · Effective date not recorded

        The apparent volume of distribution at steady-state is 7.5 ± 3.7 L/kg for venlafaxine and 5.7 ± 1.8 L/kg for ODV.
      41. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:f757cac4-efa7-668c-e053-6294a90a720d (opens source in a new tab)

        Venlafaxine label

        Version not recorded · Effective date not recorded

        The apparent volume of distribution at steady-state is 7.5 ± 3.7 L/kg for venlafaxine and 5.7 ± 1.8 L/kg for ODV.
      42. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:b18d726e-cdb2-4c80-a49d-330cddee17e9 (opens source in a new tab)

        Venlafaxine label

        Version not recorded · Effective date not recorded

        The apparent volume of distribution at steady-state is 7.5 ± 3.7 L/kg for venlafaxine and 5.7 ± 1.8 L/kg for ODV.
      43. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:6c1d0d4f-c8e2-4035-8f4e-7a46bfe3f059 (opens source in a new tab)

        Venlafaxine label

        Version not recorded · Effective date not recorded

        The apparent volume of distribution at steady-state is 7.5 ± 3.7 L/kg for venlafaxine and 5.7 ± 1.8 L/kg for ODV.
      44. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:017a84aa-0e1f-f560-e063-6294a90a9069 (opens source in a new tab)

        Venlafaxine label

        Version not recorded · Effective date not recorded

        Mean ± SD steady-state plasma clearance of venlafaxine and ODV is 1.3 ± 0.6 and 0.4 ± 0.2 L/h/kg, respectively; elimination half-life is 5 ± 2 and 11±2 hours, respectively; and steady-state volume of distribution is 7.5 ± 3.7 L/kg and 5.7 ± 1.8 L/kg, respectively.
      45. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:fda14f3f-b32c-42fe-e053-6294a90a103f (opens source in a new tab)

        Venlafaxine label

        Version not recorded · Effective date not recorded

        Mean ± SD steady-state plasma clearance of venlafaxine and ODV is 1.3 ± 0.6 and 0.4 ± 0.2 L/h/kg, respectively; elimination half-life is 5 ± 2 and 11 ± 2 hours, respectively; and steady-state volume of distribution is 7.5 ± 3.7 L/kg and 5.7 ± 1.8 L/kg, respectively.
      46. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:304bda24-9151-47b5-9f62-005ea325a11e (opens source in a new tab)

        Venlafaxine label

        Version not recorded · Effective date not recorded

        Mean ± SD steady-state plasma clearance of venlafaxine and ODV is 1.3 ± 0.6 and 0.4 ± 0.2 L/h/kg, respectively; elimination half-life is 5 ± 2 and 11 ± 2 hours, respectively; and steady-state volume of distribution is 7.5 ± 3.7 L/kg and 5.7 ± 1.8 L/kg, respectively.
      47. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:04340ccb-c3b3-41ab-a4bc-101d8b6bc1a9 (opens source in a new tab)

        Venlafaxine label

        Version not recorded · Effective date not recorded

        The apparent volume of distribution at steady-state is 7.5 ± 3.7 L/kg for venlafaxine and 5.7 ± 1.8 L/kg for ODV.
      48. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:b5fc0187-590c-4bb9-a910-821eb0dc1fc8 (opens source in a new tab)

        Venlafaxine label

        Version not recorded · Effective date not recorded

        Mean ± SD steady-state plasma clearance of venlafaxine and ODV is 1.3 ± 0.6 and 0.4 ± 0.2 L/h/kg, respectively; elimination half-life is 5 ± 2 and 11±2 hours, respectively; and steady-state volume of distribution is 7.5 ± 3.7 L/kg and 5.7 ± 1.8 L/kg, respectively.
      49. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:20a7d922-7f7c-4de4-b5fd-55c13aab060c (opens source in a new tab)

        Venlafaxine label

        Version not recorded · Effective date not recorded

        The apparent volume of distribution at steady-state is 7.5 ± 3.7 L/kg for venlafaxine and 5.7 ± 1.8 L/kg for ODV.
      50. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:2efde38c-250e-d1b9-e063-6394a90a1b74 (opens source in a new tab)

        Venlafaxine label

        Version not recorded · Effective date not recorded

        The apparent volume of distribution at steady-state is 7.5 ± 3.7 L/kg for venlafaxine and 5.7 ± 1.8 L/kg for ODV.
      51. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:7bbdc9c5-a4b9-44d4-babc-46bd8c2e084a (opens source in a new tab)

        Venlafaxine label

        Version not recorded · Effective date not recorded

        Mean ± SD steady-state plasma clearance of venlafaxine and ODV is 1.3 ± 0.6 and 0.4 ± 0.2 L/h/kg, respectively; elimination half-life is 5 ± 2 and 11±2 hours, respectively; and steady-state volume of distribution is 7.5 ± 3.7 L/kg and 5.7 ± 1.8 L/kg, respectively.
      52. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:52ce8a81-d7fc-cc97-e063-6394a90a5236 (opens source in a new tab)

        Venlafaxine label

        Version not recorded · Effective date not recorded

        Mean ± SD steady-state plasma clearance of venlafaxine and ODV is 1.3 ± 0.6 and 0.4 ± 0.2 L/h/kg, respectively; elimination half-life is 5 ± 2 and 11 ± 2 hours, respectively; and steady-state volume of distribution is 7.5 ± 3.7 L/kg and 5.7 ± 1.8 L/kg, respectively.
      53. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:f56a0f70-bbb1-4e69-b969-965a72f0e2f0 (opens source in a new tab)

        Venlafaxine label

        Version not recorded · Effective date not recorded

        Mean ± SD steady-state plasma clearance of venlafaxine and ODV is 1.3 ± 0.6 and 0.4 ± 0.2 L/h/kg, respectively; elimination half-life is 5 ± 2 and 11 ± 2 hours, respectively; and steady-state volume of distribution is 7.5 ± 3.7 L/kg and 5.7 ± 1.8 L/kg, respectively.
      54. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:3eef522f-9e95-4668-bb12-09fd47ed0daf (opens source in a new tab)

        Venlafaxine label

        Version not recorded · Effective date not recorded

        Mean ± SD steady-state plasma clearance of venlafaxine and ODV is 1.3 ± 0.6 and 0.4 ± 0.2 L/h/kg, respectively; elimination half-life is 5 ± 2 and 11 ± 2 hours, respectively; and steady-state volume of distribution is 7.5 ± 3.7 L/kg and 5.7 ± 1.8 L/kg, respectively.
      55. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:2a85bd43-419c-6ed7-e063-6294a90a84d4 (opens source in a new tab)

        Venlafaxine label

        Version not recorded · Effective date not recorded

        The apparent volume of distribution at steady-state is 7.5±3.7 L/kg for venlafaxine and 5.7±1.8 L/kg for ODV.
      56. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:bce7adf8-b4b5-4d7f-bf0d-ae1277ae3a2b (opens source in a new tab)

        Venlafaxine label

        Version not recorded · Effective date not recorded

        The apparent volume of distribution at steady-state is 7.5±3.7 L/kg for venlafaxine and 5.7±1.8 L/kg for ODV.
      57. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:e05bdeb4-07a9-441e-901b-f2aea550db2b (opens source in a new tab)

        Venlafaxine label

        Version not recorded · Effective date not recorded

        The apparent volume of distribution at steady-state is 7.5 ± 3.7 L/kg for venlafaxine and 5.7 ± 1.8 L/kg for ODV.
      58. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:35d3148b-52f3-197c-e063-6294a90a44e3 (opens source in a new tab)

        Venlafaxine label

        Version not recorded · Effective date not recorded

        The apparent volume of distribution at steady-state is 7.5 ± 3.7 L/kg for venlafaxine and 5.7 ± 1.8 L/kg for ODV.
      59. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:d3475ce0-1368-4961-a9b9-44c5c33cdc58 (opens source in a new tab)

        Venlafaxine label

        Version not recorded · Effective date not recorded

        Mean ± SD steady-state plasma clearance of venlafaxine and ODV is 1.3 ± 0.6 and 0.4 ± 0.2 L/h/kg, respectively; elimination half-life is 5 ± 2 and 11±2 hours, respectively; and steady-state volume of distribution is 7.5 ± 3.7 L/kg and 5.7 ± 1.8 L/kg, respectively.
      60. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:19b1543e-d599-a869-e063-6294a90a8e28 (opens source in a new tab)

        Venlafaxine label

        Version not recorded · Effective date not recorded

        The apparent volume of distribution at steady-state is 7.5±3.7 L/kg for venlafaxine and 5.7±1.8 L/kg for ODV.
      61. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:5bd03cf1-e8fc-44f3-9c41-06515b897f3b (opens source in a new tab)

        Venlafaxine label

        Version not recorded · Effective date not recorded

        Mean ± SD steady-state plasma clearance of venlafaxine and ODV is 1.3 ± 0.6 and 0.4 ± 0.2 L/h/kg, respectively; elimination half-life is 5 ± 2 and 11 ± 2 hours, respectively; and steady-state volume of distribution is 7.5 ± 3.7 L/kg and 5.7 ± 1.8 L/kg, respectively.
      62. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:2787aaa2-5210-f7d5-e063-6294a90a7103 (opens source in a new tab)

        Venlafaxine label

        Version not recorded · Effective date not recorded

        The apparent volume of distribution at steady-state is 7.5 ± 3.7 L/kg for venlafaxine and 5.7 ± 1.8 L/kg for ODV.
      63. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:f89bcae0-e714-599a-e053-6294a90a2c3a (opens source in a new tab)

        Venlafaxine label

        Version not recorded · Effective date not recorded

        The apparent volume of distribution at steady-state is 7.5 ± 3.7 L/kg for venlafaxine and 5.7 ± 1.8 L/kg for ODV.
      64. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:fa1db21b-98b8-3bde-e053-6394a90aa638 (opens source in a new tab)

        Venlafaxine label

        Version not recorded · Effective date not recorded

        Mean ± SD steady-state plasma clearance of venlafaxine and ODV is 1.3 ± 0.6 and 0.4 ± 0.2 L/h/kg, respectively; elimination half-life is 5 ± 2 and 11±2 hours, respectively; and steady-state volume of distribution is 7.5 ± 3.7 L/kg and 5.7 ± 1.8 L/kg, respectively.
      65. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:53c29dd9-a4d2-7537-e063-6294a90a290f (opens source in a new tab)

        Venlafaxine label

        Version not recorded · Effective date not recorded

        Mean ± SD steady-state plasma clearance of venlafaxine and ODV is 1.3 ± 0.6 and 0.4 ± 0.2 L/h/kg, respectively; elimination half-life is 5 ± 2 and 11 ± 2 hours, respectively; and steady-state volume of distribution is 7.5 ± 3.7 L/kg and 5.7 ± 1.8 L/kg, respectively.
      66. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:b1d21366-f686-4e20-a10f-0c25f517db38 (opens source in a new tab)

        Venlafaxine label

        Version not recorded · Effective date not recorded

        The apparent volume of distribution at steady-state is 7.5±3.7 L/kg for venlafaxine and 5.7±1.8 L/kg for ODV.
      67. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:3e51f786-3691-4ec4-836b-7f2c9a385aa7 (opens source in a new tab)

        Venlafaxine label

        Version not recorded · Effective date not recorded

        The apparent volume of distribution at steady-state is 7.5 ± 3.7 L/kg for venlafaxine and 5.7 ± 1.8 L/kg for ODV.
      68. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:1a9e207a-aba5-4ecb-b7b6-7c1e38be5ac9 (opens source in a new tab)

        Venlafaxine label

        Version not recorded · Effective date not recorded

        The apparent volume of distribution at steady-state is 7.5 ± 3.7 L/kg for venlafaxine and 5.7 ± 1.8 L/kg for ODV.
      69. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:0c9511a2-c581-44cd-bf38-a751fcc658e4 (opens source in a new tab)

        Venlafaxine label

        Version not recorded · Effective date not recorded

        Mean ± SD steady-state plasma clearance of venlafaxine and ODV is 1.3 ± 0.6 and 0.4 ± 0.2 L/h/kg, respectively; elimination half-life is 5 ± 2 and 11 ± 2 hours, respectively; and steady-state volume of distribution is 7.5 ± 3.7 L/kg and 5.7 ± 1.8 L/kg, respectively.
      70. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:1bf78b22-a0e3-5f9f-e063-6394a90a3024 (opens source in a new tab)

        Venlafaxine label

        Version not recorded · Effective date not recorded

        The apparent volume of distribution at steady-state is 7.5±3.7 L/kg for venlafaxine and 5.7±1.8 L/kg for ODV.
      71. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:20319949-ccf9-477a-a6e3-53502772deb9 (opens source in a new tab)

        Venlafaxine label

        Version not recorded · Effective date not recorded

        Mean ± SD steady-state plasma clearance of venlafaxine and ODV is 1.3 ± 0.6 and 0.4 ± 0.2 L/h/kg, respectively; elimination half-life is 5 ± 2 and 11 ± 2 hours, respectively; and steady-state volume of distribution is 7.5 ± 3.7 L/kg and 5.7 ± 1.8 L/kg, respectively.
      72. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:9e745ad7-be4f-4369-be23-587e1154e4ab (opens source in a new tab)

        Venlafaxine label

        Version not recorded · Effective date not recorded

        The apparent volume of distribution at steady-state is 7.5 ± 3.7 L/kg for venlafaxine and 5.7 ± 1.8 L/kg for ODV.
      73. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:f2b5c729-17c8-7ecc-e053-2a95a90a2e53 (opens source in a new tab)

        Venlafaxine label

        Version not recorded · Effective date not recorded

        Mean ± SD steady-state plasma clearance of venlafaxine and ODV is 1.3 ± 0.6 and 0.4 ± 0.2 L/h/kg, respectively; elimination half-life is 5 ± 2 and 11 ± 2 hours, respectively; and steady-state volume of distribution is 7.5 ± 3.7 L/kg and 5.7 ± 1.8 L/kg, respectively.
      74. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:806b3e38-3b2a-4aaa-973c-e2d921bb353e (opens source in a new tab)

        Venlafaxine label

        Version not recorded · Effective date not recorded

        Mean ± SD steady-state plasma clearance of venlafaxine and ODV is 1.3 ± 0.6 and 0.4 ± 0.2 L/h/kg, respectively; elimination half-life is 5 ± 2 and 11 ± 2 hours, respectively; and steady-state volume of distribution is 7.5 ± 3.7 L/kg and 5.7 ± 1.8 L/kg, respectively.
      75. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:67059969-e291-4609-b130-0faacf2a19f0 (opens source in a new tab)

        Venlafaxine label

        Version not recorded · Effective date not recorded

        The apparent volume of distribution at steady-state is 7.5 ± 3.7 L/kg for venlafaxine and 5.7 ± 1.8 L/kg for ODV.
      76. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:48a75840-64e4-4d44-9a62-009373003105 (opens source in a new tab)

        Venlafaxine label

        Version not recorded · Effective date not recorded

        The apparent volume of distribution at steady-state is 7.5 ± 3.7 L/kg for venlafaxine and 5.7 ± 1.8 L/kg for ODV.
      77. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:9a30e1b5-272b-4109-ad6c-a3c9a895822f (opens source in a new tab)

        Venlafaxine label

        Version not recorded · Effective date not recorded

        The apparent volume of distribution at steady-state is 7.5 ± 3.7 L/kg for venlafaxine and 5.7 ± 1.8 L/kg for ODV.
      78. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:3c2e188f-76aa-a022-e063-6294a90abfc9 (opens source in a new tab)

        Venlafaxine label

        Version not recorded · Effective date not recorded

        The apparent volume of distribution at steady-state is 7.5 ± 3.7 L/kg for venlafaxine and 5.7 ± 1.8 L/kg for ODV.
      79. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:bff505db-2752-41fc-a4dd-4773f629106e (opens source in a new tab)

        Venlafaxine label

        Version not recorded · Effective date not recorded

        The apparent volume of distribution at steady-state is 7.5 ± 3.7 L/kg for venlafaxine and 5.7 ± 1.8 L/kg for ODV.
      80. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:85d3ce8b-8966-45d9-bdaf-f6f0475096e1 (opens source in a new tab)

        Venlafaxine label

        Version not recorded · Effective date not recorded

        The apparent volume of distribution at steady-state is 7.5 ± 3.7 L/kg for venlafaxine and 5.7 ± 1.8 L/kg for ODV.
      81. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:5c558ab8-b4b3-4973-b016-ed5cfcb4d88b (opens source in a new tab)

        Venlafaxine label

        Version not recorded · Effective date not recorded

        The apparent volume of distribution at steady-state is 7.5 ± 3.7 L/kg for venlafaxine and 5.7 ± 1.8 L/kg for ODV.
      82. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:ded77a84-e6d1-4471-ac6e-a05a0955daa5 (opens source in a new tab)

        Venlafaxine label

        Version not recorded · Effective date not recorded

        Mean ± SD steady-state plasma clearance of venlafaxine and ODV is 1.3 ± 0.6 and 0.4 ± 0.2 L/h/kg, respectively; elimination half-life is 5 ± 2 and 11 ± 2 hours, respectively; and steady-state volume of distribution is 7.5 ± 3.7 L/kg and 5.7 ± 1.8 L/kg, respectively.
      83. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:d8899628-6e1b-40c6-9bc8-553d91ae2d0c (opens source in a new tab)

        Venlafaxine label

        Version not recorded · Effective date not recorded

        Mean ± SD steady-state plasma clearance of venlafaxine and ODV is 1.3 ± 0.6 and 0.4 ± 0.2 L/h/kg, respectively; elimination half-life is 5 ± 2 and 11±2 hours, respectively; and steady-state volume of distribution is 7.5 ± 3.7 L/kg and 5.7 ± 1.8 L/kg, respectively.
      84. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:fe7de51e-8a81-fe68-e053-6294a90a7339 (opens source in a new tab)

        Venlafaxine label

        Version not recorded · Effective date not recorded

        Mean ± SD steady-state plasma clearance of venlafaxine and ODV is 1.3 ± 0.6 and 0.4 ± 0.2 L/h/kg, respectively; elimination half-life is 5 ± 2 and 11±2 hours, respectively; and steady-state volume of distribution is 7.5 ± 3.7 L/kg and 5.7 ± 1.8 L/kg, respectively.
      85. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:c848a5d8-ba94-4c84-80e3-0bf35fb8e32e (opens source in a new tab)

        Venlafaxine label

        Version not recorded · Effective date not recorded

        The apparent volume of distribution at steady-state is 7.5 ± 3.7 L/kg for venlafaxine and 5.7 ± 1.8 L/kg for ODV.
      86. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:0c404290-2806-4756-bca3-2d639b400963 (opens source in a new tab)

        Venlafaxine label

        Version not recorded · Effective date not recorded

        The apparent volume of distribution at steady-state is 7.5 ± 3.7 L/kg for venlafaxine and 5.7 ± 1.8 L/kg for ODV.
      87. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:fb076577-b9da-c78b-e053-6394a90a107b (opens source in a new tab)

        Venlafaxine label

        Version not recorded · Effective date not recorded

        Mean ± SD steady-state plasma clearance of venlafaxine and ODV is 1.3 ± 0.6 and 0.4 ± 0.2 L/h/kg, respectively; elimination half-life is 5 ± 2 and 11 ± 2 hours, respectively; and steady-state volume of distribution is 7.5 ± 3.7 L/kg and 5.7 ± 1.8 L/kg, respectively.
      88. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:db5f1693-ca64-7a97-e053-2995a90acbff (opens source in a new tab)

        Venlafaxine label

        Version not recorded · Effective date not recorded

        Mean ± SD steady-state plasma clearance of venlafaxine and ODV is 1.3 ± 0.6 and 0.4 ± 0.2 L/h/kg, respectively; elimination half-life is 5 ± 2 and 11 ± 2 hours, respectively; and steady-state volume of distribution is 7.5 ± 3.7 L/kg and 5.7 ± 1.8 L/kg, respectively.
      89. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:85740bf6-7e88-4a6e-9ec9-3455e3b95e59 (opens source in a new tab)

        Venlafaxine label

        Version not recorded · Effective date not recorded

        The apparent volume of distribution at steady-state is 7.5 ± 3.7 L/kg for venlafaxine and 5.7 ± 1.8 L/kg for ODV.
      90. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:ddb51556-0292-4aa9-b781-a402c912591f (opens source in a new tab)

        Venlafaxine label

        Version not recorded · Effective date not recorded

        Mean ± SD steady-state plasma clearance of venlafaxine and ODV is 1.3 ± 0.6 and 0.4 ± 0.2 L/h/kg, respectively; elimination half-life is 5 ± 2 and 11 ± 2 hours, respectively; and steady-state volume of distribution is 7.5 ± 3.7 L/kg and 5.7 ± 1.8 L/kg, respectively.
      91. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:e3e238db-4388-49bb-aa67-6d73adbb2280 (opens source in a new tab)

        Venlafaxine label

        Version not recorded · Effective date not recorded

        The apparent volume of distribution at steady-state is 7.5 ± 3.7 L/kg for venlafaxine and 5.7 ± 1.8 L/kg for ODV.
      92. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:7588ffdc-034d-4baf-9889-9a0ded265be5 (opens source in a new tab)

        Venlafaxine label

        Version not recorded · Effective date not recorded

        The apparent volume of distribution at steady-state is 7.5 ± 3.7 L/kg for venlafaxine and 5.7 ± 1.8 L/kg for ODV.
      93. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:e2fa1bb0-ab86-4499-84cb-ff5e02a16991 (opens source in a new tab)

        Venlafaxine label

        Version not recorded · Effective date not recorded

        The apparent volume of distribution at steady-state is 7.5 ± 3.7 L/kg for venlafaxine and 5.7 ± 1.8 L/kg for ODV.
      94. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:37aaa8ac-4e0c-4e04-98b5-19b0d90d857c (opens source in a new tab)

        Venlafaxine label

        Version not recorded · Effective date not recorded

        Mean ± SD steady-state plasma clearance of venlafaxine and ODV is 1.3 ± 0.6 and 0.4 ± 0.2 L/h/kg, respectively; elimination half-life is 5 ± 2 and 11 ± 2 hours, respectively; and steady-state volume of distribution is 7.5 ± 3.7 L/kg and 5.7 ± 1.8 L/kg, respectively.
      95. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:53e5c5a2-b8e7-3d75-e063-6294a90a508b (opens source in a new tab)

        Venlafaxine label

        Version not recorded · Effective date not recorded

        Mean ± SD steady-state plasma clearance of venlafaxine and ODV is 1.3 ± 0.6 and 0.4 ± 0.2 L/h/kg, respectively; elimination half-life is 5 ± 2 and 11 ± 2 hours, respectively; and steady-state volume of distribution is 7.5 ± 3.7 L/kg and 5.7 ± 1.8 L/kg, respectively.
      96. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:4a82cef5-693e-46e9-90c4-bff753cdce37 (opens source in a new tab)

        Venlafaxine label

        Version not recorded · Effective date not recorded

        Mean ± SD steady-state plasma clearance of venlafaxine and ODV is 1.3 ± 0.6 and 0.4 ± 0.2 L/h/kg, respectively; elimination half-life is 5 ± 2 and 11 ± 2 hours, respectively; and steady-state volume of distribution is 7.5 ± 3.7 L/kg and 5.7 ± 1.8 L/kg, respectively.
      97. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:0aedeaf8-9b6c-4a44-a5fe-9d74516f542d (opens source in a new tab)

        Venlafaxine label

        Version not recorded · Effective date not recorded

        The apparent volume of distribution at steady-state is 7.5 ± 3.7 L/kg for venlafaxine and 5.7 ± 1.8 L/kg for ODV.
      98. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:b23637e5-d37f-41b5-ba76-fc053e903bc2 (opens source in a new tab)

        Venlafaxine label

        Version not recorded · Effective date not recorded

        Mean ± SD steady-state plasma clearance of venlafaxine and ODV is 1.3 ± 0.6 and 0.4 ± 0.2 L/h/kg, respectively; elimination half-life is 5 ± 2 and 11 ± 2 hours, respectively; and steady-state volume of distribution is 7.5 ± 3.7 L/kg and 5.7 ± 1.8 L/kg, respectively.
      99. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:172b3d3d-bdae-47bf-8fba-edd6da1a8649 (opens source in a new tab)

        Venlafaxine label

        Version not recorded · Effective date not recorded

        Mean ± SD steady-state plasma clearance of venlafaxine and ODV is 1.3 ± 0.6 and 0.4 ± 0.2 L/h/kg, respectively; elimination half-life is 5 ± 2 and 11±2 hours, respectively; and steady-state volume of distribution is 7.5 ± 3.7 L/kg and 5.7 ± 1.8 L/kg, respectively.
      100. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:185d90ab-1ba4-dd59-0565-e35f0fd39a2d (opens source in a new tab)

        Venlafaxine label

        Version not recorded · Effective date not recorded

        Mean ± SD steady-state plasma clearance of venlafaxine and ODV is 1.3 ± 0.6 and 0.4 ± 0.2 L/h/kg, respectively; elimination half-life is 5 ± 2 and 11±2 hours, respectively; and steady-state volume of distribution is 7.5 ± 3.7 L/kg and 5.7 ± 1.8 L/kg, respectively.
      101. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:22980b32-cbae-4f37-9fc0-b47221b2c32e (opens source in a new tab)

        Venlafaxine label

        Version not recorded · Effective date not recorded

        The apparent volume of distribution at steady-state is 7.5 ± 3.7 L/kg for venlafaxine and 5.7 ± 1.8 L/kg for ODV.
      102. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:de6e30f8-c8ef-4016-b228-0f188645347b (opens source in a new tab)

        Venlafaxine label

        Version not recorded · Effective date not recorded

        The apparent volume of distribution at steady-state is 7.5 ± 3.7 L/kg for venlafaxine and 5.7 ± 1.8 L/kg for ODV.
      103. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:e2d5a2d5-5e55-426c-bc8d-d29729eba775 (opens source in a new tab)

        Venlafaxine label

        Version not recorded · Effective date not recorded

        The apparent volume of distribution at steady-state is 7.5 ± 3.7 L/kg for venlafaxine and 5.7 ± 1.8 L/kg for ODV.
      104. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:28c8f404-1dbd-4140-8959-32624d7c7724 (opens source in a new tab)

        Venlafaxine label

        Version not recorded · Effective date not recorded

        The apparent volume of distribution at steady-state is 7.5 ± 3.7 L/kg for venlafaxine and 5.7 ± 1.8 L/kg for ODV.
      105. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:2a7d760c-fd9f-8026-e063-6294a90aaa43 (opens source in a new tab)

        Venlafaxine label

        Version not recorded · Effective date not recorded

        The apparent volume of distribution at steady-state is 7.5 ± 3.7 L/kg for venlafaxine and 5.7 ± 1.8 L/kg for ODV.
      106. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:1775b8bf-cd4f-4a8a-abd1-78d90de54fdd (opens source in a new tab)

        Venlafaxine label

        Version not recorded · Effective date not recorded

        The apparent volume of distribution at steady-state is 7.5 ± 3.7 L/kg for venlafaxine and 5.7 ± 1.8 L/kg for ODV.
      107. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:70d47b50-5722-3868-e053-2991aa0af85e (opens source in a new tab)

        Venlafaxine label

        Version not recorded · Effective date not recorded

        Mean ± SD steady-state plasma clearance of venlafaxine and ODV is 1.3 ± 0.6 and 0.4 ± 0.2 L/h/kg, respectively; elimination half-life is 5 ± 2 and 11 ± 2 hours, respectively; and steady-state volume of distribution is 7.5 ± 3.7 L/kg and 5.7 ± 1.8 L/kg, respectively.
      108. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:d94e5404-f728-4e4b-af99-8a8e4dfae227 (opens source in a new tab)

        Venlafaxine label

        Version not recorded · Effective date not recorded

        The apparent volume of distribution at steady-state is 7.5±3.7 L/kg for venlafaxine and 5.7±1.8 L/kg for ODV.
      109. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:f50029b8-7d05-445a-9d9f-71a1aee6088b (opens source in a new tab)

        Venlafaxine label

        Version not recorded · Effective date not recorded

        The apparent volume of distribution at steady-state is 7.5±3.7 L/kg for venlafaxine and 5.7±1.8 L/kg for ODV.
      110. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:f5c21429-d5d0-9f93-a465-6e5e0e19ebdd (opens source in a new tab)

        Venlafaxine label

        Version not recorded · Effective date not recorded

        The apparent volume of distribution at steady-state is 7.5 ± 3.7 L/kg for venlafaxine and 5.7 ± 1.8 L/kg for ODV.
      111. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:106d0d7b-925b-74e7-83cb-562144ce1f92 (opens source in a new tab)

        Venlafaxine label

        Version not recorded · Effective date not recorded

        Mean ± SD steady-state plasma clearance of venlafaxine and ODV is 1.3 ± 0.6 and 0.4 ± 0.2 L/h/kg, respectively; elimination half-life is 5 ± 2 and 11 ± 2 hours, respectively; and steady-state volume of distribution is 7.5 ± 3.7 L/kg and 5.7 ± 1.8 L/kg, respectively.
      112. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:49e5833b-4693-45b5-9abb-1b369eb4086d (opens source in a new tab)

        Venlafaxine label

        Version not recorded · Effective date not recorded

        Mean ± SD steady-state plasma clearance of venlafaxine and ODV is 1.3 ± 0.6 and 0.4 ± 0.2 L/h/kg, respectively; elimination half-life is 5 ± 2 and 11 ± 2 hours, respectively; and steady-state volume of distribution is 7.5 ± 3.7 L/kg and 5.7 ± 1.8 L/kg, respectively.
      113. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:1e04fe02-88c9-dafd-e063-6294a90ac4c9 (opens source in a new tab)

        Venlafaxine label

        Version not recorded · Effective date not recorded

        The apparent volume of distribution at steady-state is 7.5±3.7 L/kg for venlafaxine and 5.7±1.8 L/kg for ODV.
      114. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:e14bfb9f-3bd2-4419-9294-9c286e79730a (opens source in a new tab)

        Venlafaxine label

        Version not recorded · Effective date not recorded

        Mean ± SD steady-state plasma clearance of venlafaxine and ODV is 1.3 ± 0.6 and 0.4 ± 0.2 L/h/kg, respectively; elimination half-life is 5 ± 2 and 11 ± 2 hours, respectively; and steady-state volume of distribution is 7.5 ± 3.7 L/kg and 5.7 ± 1.8 L/kg, respectively.
      115. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:b055df74-51f9-401f-8cca-24269a0163df (opens source in a new tab)

        Venlafaxine label

        Version not recorded · Effective date not recorded

        The apparent volume of distribution at steady-state is 7.5±3.7 L/kg for venlafaxine and 5.7±1.8 L/kg for ODV.
      116. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:d962f5af-7642-4c6e-b7be-3e089fe48873 (opens source in a new tab)

        Venlafaxine label

        Version not recorded · Effective date not recorded

        The apparent volume of distribution at steady-state is 7.5 ± 3.7 L/kg for venlafaxine and 5.7 ± 1.8 L/kg for ODV.
      117. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:c41d847b-88ba-49a5-9d73-269ac4caa4ed (opens source in a new tab)

        Venlafaxine label

        Version not recorded · Effective date not recorded

        The apparent volume of distribution at steady-state is 7.5 ± 3.7 L/kg for venlafaxine and 5.7 ± 1.8 L/kg for ODV.
      118. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:dabfa0f2-0060-f0ee-e053-2a95a90aec9b (opens source in a new tab)

        Venlafaxine label

        Version not recorded · Effective date not recorded

        Mean ± SD steady-state plasma clearance of venlafaxine and ODV is 1.3 ± 0.6 and 0.4 ± 0.2 L/h/kg, respectively; elimination half-life is 5 ± 2 and 11 ± 2 hours, respectively; and steady-state volume of distribution is 7.5 ± 3.7 L/kg and 5.7 ± 1.8 L/kg, respectively.
      119. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:296d6ab7-8c0c-40e5-8cb2-9d125b42b8bb (opens source in a new tab)

        Venlafaxine label

        Version not recorded · Effective date not recorded

        The apparent volume of distribution at steady-state is 7.5 ± 3.7 L/kg for venlafaxine and 5.7 ± 1.8 L/kg for ODV.
      120. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:569e10d1-6432-473c-a026-ac438bd77bcd (opens source in a new tab)

        Venlafaxine label

        Version not recorded · Effective date not recorded

        The apparent volume of distribution at steady-state is 7.5 ± 3.7 L/kg for venlafaxine and 5.7 ± 1.8 L/kg for ODV.
      121. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:fab65158-b2f7-1db7-e053-6294a90af231 (opens source in a new tab)

        Venlafaxine label

        Version not recorded · Effective date not recorded

        Mean ± SD steady-state plasma clearance of venlafaxine and ODV is 1.3 ± 0.6 and 0.4 ± 0.2 L/h/kg, respectively; elimination half-life is 5 ± 2 and 11±2 hours, respectively; and steady-state volume of distribution is 7.5 ± 3.7 L/kg and 5.7 ± 1.8 L/kg, respectively.
      122. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:c2a3283f-ba30-f506-e053-2995a90a9378 (opens source in a new tab)

        Venlafaxine label

        Version not recorded · Effective date not recorded

        Mean ± SD steady-state plasma clearance of venlafaxine and ODV is 1.3 ± 0.6 and 0.4 ± 0.2 L/h/kg, respectively; elimination half-life is 5 ± 2 and 11 ± 2 hours, respectively; and steady-state volume of distribution is 7.5 ± 3.7 L/kg and 5.7 ± 1.8 L/kg, respectively.
      123. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:55889b3d-74c9-4638-9a14-6a4ca3a99f7f (opens source in a new tab)

        Venlafaxine label

        Version not recorded · Effective date not recorded

        Mean ± SD steady-state plasma clearance of venlafaxine and ODV is 1.3 ± 0.6 and 0.4 ± 0.2 L/h/kg, respectively; elimination half-life is 5 ± 2 and 11 ± 2 hours, respectively; and steady-state volume of distribution is 7.5 ± 3.7 L/kg and 5.7 ± 1.8 L/kg, respectively.
      124. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:b73da6e2-1494-436f-a204-2e4e4c5974b6 (opens source in a new tab)

        Venlafaxine label

        Version not recorded · Effective date not recorded

        Mean ± SD steady-state plasma clearance of venlafaxine and ODV is 1.3 ± 0.6 and 0.4 ± 0.2 L/h/kg, respectively; elimination half-life is 5 ± 2 and 11 ± 2 hours, respectively; and steady-state volume of distribution is 7.5 ± 3.7 L/kg and 5.7 ± 1.8 L/kg, respectively.
      125. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:3cbe3e18-9a7e-aaa3-e063-6394a90abf92 (opens source in a new tab)

        Venlafaxine label

        Version not recorded · Effective date not recorded

        The apparent volume of distribution at steady-state is 7.5 ± 3.7 L/kg for venlafaxine and 5.7 ± 1.8 L/kg for ODV.
      126. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:67b323a7-a8c9-410f-bff0-0e515bef41a7 (opens source in a new tab)

        Venlafaxine label

        Version not recorded · Effective date not recorded

        Mean ± SD steady-state plasma clearance of venlafaxine and ODV is 1.3 ± 0.6 and 0.4 ± 0.2 L/h/kg, respectively; elimination half-life is 5 ± 2 and 11 ± 2 hours, respectively; and steady-state volume of distribution is 7.5 ± 3.7 L/kg and 5.7 ± 1.8 L/kg, respectively.
      127. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:1471508e-7fe4-43db-94ea-b4df1bcbafa9 (opens source in a new tab)

        Venlafaxine label

        Version not recorded · Effective date not recorded

        Mean ± SD steady-state plasma clearance of venlafaxine and ODV is 1.3 ± 0.6 and 0.4 ± 0.2 L/h/kg, respectively; elimination half-life is 5 ± 2 and 11±2 hours, respectively; and steady-state volume of distribution is 7.5 ± 3.7 L/kg and 5.7 ± 1.8 L/kg, respectively.
      128. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:ab58f3ef-1fd3-4c68-861f-20d8fdd1b433 (opens source in a new tab)

        Venlafaxine label

        Version not recorded · Effective date not recorded

        Mean ± SD steady-state plasma clearance of venlafaxine and ODV is 1.3 ± 0.6 and 0.4 ± 0.2 L/h/kg, respectively; elimination half-life is 5 ± 2 and 11 ± 2 hours, respectively; and steady-state volume of distribution is 7.5 ± 3.7 L/kg and 5.7 ± 1.8 L/kg, respectively.
      129. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:653f3f95-98d0-4ce0-bf10-ac7938be690e (opens source in a new tab)

        Venlafaxine label

        Version not recorded · Effective date not recorded

        The apparent volume of distribution at steady-state is 7.5 ± 3.7 L/kg for venlafaxine and 5.7 ± 1.8 L/kg for ODV.
      130. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:d4638a83-2720-430c-b529-c852aa2f7366 (opens source in a new tab)

        Venlafaxine label

        Version not recorded · Effective date not recorded

        Mean ± SD steady-state plasma clearance of venlafaxine and ODV is 1.3 ± 0.6 and 0.4 ± 0.2 L/h/kg, respectively; elimination half-life is 5 ± 2 and 11±2 hours, respectively; and steady-state volume of distribution is 7.5 ± 3.7 L/kg and 5.7 ± 1.8 L/kg, respectively.
      131. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:cb4c04a6-47d1-44ff-8d58-718102fa08eb (opens source in a new tab)

        Venlafaxine label

        Version not recorded · Effective date not recorded

        The apparent volume of distribution at steady-state is 7.5 ± 3.7 L/kg for venlafaxine and 5.7 ± 1.8 L/kg for ODV.
      132. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:7aa3edba-4248-49bb-86f7-06fdbf2a6fb7 (opens source in a new tab)

        Venlafaxine label

        Version not recorded · Effective date not recorded

        The apparent volume of distribution at steady-state is 7.5 ± 3.7 L/kg for venlafaxine and 5.7 ± 1.8 L/kg for ODV.
      133. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:18495527-add4-42a5-bbf7-9f8dc2df06af (opens source in a new tab)

        Venlafaxine label

        Version not recorded · Effective date not recorded

        Mean ± SD steady-state plasma clearance of venlafaxine and ODV is 1.3 ± 0.6 and 0.4 ± 0.2 L/h/kg, respectively; elimination half-life is 5 ± 2 and 11 ± 2 hours, respectively; and steady-state volume of distribution is 7.5 ± 3.7 L/kg and 5.7 ± 1.8 L/kg, respectively.
      134. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:5358f20f-b864-0aae-e063-6394a90a7eab (opens source in a new tab)

        Venlafaxine label

        Version not recorded · Effective date not recorded

        The apparent volume of distribution at steady-state is 7.5 ± 3.7 L/kg for venlafaxine and 5.7 ± 1.8 L/kg for ODV.
      135. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:80ac757d-c629-4579-8afd-cae0ee9cd614 (opens source in a new tab)

        Venlafaxine label

        Version not recorded · Effective date not recorded

        Mean ± SD steady-state plasma clearance of venlafaxine and ODV is 1.3 ± 0.6 and 0.4 ± 0.2 L/h/kg, respectively; elimination half-life is 5 ± 2 and 11 ± 2 hours, respectively; and steady-state volume of distribution is 7.5 ± 3.7 L/kg and 5.7 ± 1.8 L/kg, respectively.
      136. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:5a990dbd-f280-4caf-b950-4703ee98b230 (opens source in a new tab)

        Venlafaxine label

        Version not recorded · Effective date not recorded

        The apparent volume of distribution at steady-state is 7.5±3.7 L/kg for venlafaxine and 5.7±1.8 L/kg for ODV.
      137. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:50d3b487-9f65-4e2f-b6eb-9533964f8972 (opens source in a new tab)

        Venlafaxine label

        Version not recorded · Effective date not recorded

        The apparent volume of distribution at steady-state is 7.5 ± 3.7 L/kg for venlafaxine and 5.7 ± 1.8 L/kg for ODV.

    2. 1375 L

      Numeric value
      1,375
      Unit
      L
      Source records
      1

      Population and context: Unknown: population and formulation context were not structurally extracted from this source sentence.

      Show all 1 source records
      1. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:e81a2daf-b8b2-7c05-b532-bc775700b100 (opens source in a new tab)

        Venlafaxine label

        Version not recorded · Effective date not recorded

        Following a single 112.5 mg dose of Venlafaxine Extended-Release Tablets, the mean apparent volume of distribution (V z /F) of venlafaxine is 1375 L.

  4. Projected row 1624

    Medicine slug
    vepdegestrant
    Compared field
    halfLife
    Comparison state
    agree
    Reason codes
    • COMPATIBLE_VALUES_OVERLAP
    Documents examined
    2
    Source count
    2
    Agreement rate
    1
    Recorded readings

    1. 19 hours

      Numeric value
      19
      Unit
      hours
      Source records
      2

      Population and context: Unknown: population and formulation context were not structurally extracted from this source sentence.

      Show all 2 source records
      1. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:484e21ba-8fe1-4c6d-b923-8ba4cf5b2f20 (opens source in a new tab)

        Vepdegestrant label

        Version not recorded · Effective date not recorded

        Elimination Vepdegestrant effective elimination half-life is 19 hours (50%) with an apparent (oral) clearance of 12 L/h (36%).
      2. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:751e18d5-1d41-4b67-b1f3-10272ca5312d (opens source in a new tab)

        Vepdegestrant label

        Version not recorded · Effective date not recorded

        Elimination Vepdegestrant effective elimination half-life is 19 hours (50%) with an apparent (oral) clearance of 12 L/h (36%).

  5. Projected row 1625

    Medicine slug
    vepdegestrant
    Compared field
    proteinBinding
    Comparison state
    agree
    Reason codes
    • COMPATIBLE_VALUES_OVERLAP
    Documents examined
    2
    Source count
    2
    Agreement rate
    1
    Recorded readings

    1. >99%

      Numeric value
      99
      Unit
      %
      Source records
      2

      Population and context: Unknown: population and formulation context were not structurally extracted from this source sentence.

      Show all 2 source records
      1. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:484e21ba-8fe1-4c6d-b923-8ba4cf5b2f20 (opens source in a new tab)

        Vepdegestrant label

        Version not recorded · Effective date not recorded

        Distribution Vepdegestrant plasma protein binding is >99%.
      2. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:751e18d5-1d41-4b67-b1f3-10272ca5312d (opens source in a new tab)

        Vepdegestrant label

        Version not recorded · Effective date not recorded

        Distribution Vepdegestrant plasma protein binding is >99%.

  6. Projected row 1626

    Medicine slug
    vepdegestrant
    Compared field
    volumeOfDistribution
    Comparison state
    agree
    Reason codes
    • COMPATIBLE_VALUES_OVERLAP
    Documents examined
    2
    Source count
    2
    Agreement rate
    1
    Recorded readings

    1. 764 L

      Numeric value
      764
      Unit
      L
      Source records
      2

      Population and context: Unknown: population and formulation context were not structurally extracted from this source sentence.

      Show all 2 source records
      1. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:484e21ba-8fe1-4c6d-b923-8ba4cf5b2f20 (opens source in a new tab)

        Vepdegestrant label

        Version not recorded · Effective date not recorded

        The apparent (oral) volume of distribution is 764 L (26%) following a single 200 mg dose.
      2. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:751e18d5-1d41-4b67-b1f3-10272ca5312d (opens source in a new tab)

        Vepdegestrant label

        Version not recorded · Effective date not recorded

        The apparent (oral) volume of distribution is 764 L (26%) following a single 200 mg dose.

  7. Projected row 1627

    Medicine slug
    verapamil
    Compared field
    bioavailability
    Comparison state
    insufficient_context
    Reason codes
    • STRUCTURED_CONTEXT_MISSING
    Documents examined
    93
    Source count
    57
    Agreement rate
    0.964912
    Recorded readings

    1. 20%

      Numeric value
      20
      Unit
      %
      Source records
      55

      Population and context: Unknown: population and formulation context were not structurally extracted from this source sentence.

      Show all 55 source records
      1. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:c7a54ee0-80c0-4c7e-a6a3-cb60142f860c (opens source in a new tab)

        Verapamil label

        Version not recorded · Effective date not recorded

        Because of rapid biotransformation of verapamil during its first pass through the portal circulation, bioavailability ranges from 20% to 35%.
      2. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:d7c29dfd-3968-41ac-a081-e670f9bd605c (opens source in a new tab)

        Verapamil label

        Version not recorded · Effective date not recorded

        Because of rapid biotransformation of verapamil during its first pass through the portal circulation, bioavailability ranges from 20% to 35%.
      3. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:ba1bf1ae-9347-4d17-998b-14bf7b5984ce (opens source in a new tab)

        Verapamil label

        Version not recorded · Effective date not recorded

        Because of rapid biotransformation of verapamil during its first pass through the portal circulation, bioavailability ranges from 20% to 35%.
      4. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:ebc9a09a-7b5f-4df6-ace7-31185d469b28 (opens source in a new tab)

        Verapamil label

        Version not recorded · Effective date not recorded

        Because of rapid biotransformation of verapamil during its first pass through the portal circulation, bioavailability ranges from 20% to 35%.
      5. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:e08c07bf-58b4-6fa2-e053-2a95a90aca32 (opens source in a new tab)

        Verapamil label

        Version not recorded · Effective date not recorded

        Because of rapid biotransformation of verapamil during its first pass through the portal circulation, bioavailability ranges from 20% to 35%.
      6. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:5dc5f087-c8da-4ed0-b532-ae44508958aa (opens source in a new tab)

        Verapamil label

        Version not recorded · Effective date not recorded

        Because of rapid biotransformation of verapamil during its first pass through the portal circulation, bioavailability ranges from 20% to 35%.
      7. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:5501208c-aa2b-47aa-89f7-87f4d4a73fd0 (opens source in a new tab)

        Verapamil label

        Version not recorded · Effective date not recorded

        Because of rapid biotransformation of verapamil during its first pass through the portal circulation, bioavailability ranges from 20% to 35%.
      8. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:f00c1caf-68b6-40c1-a1fa-72d17d2cf44f (opens source in a new tab)

        Verapamil label

        Version not recorded · Effective date not recorded

        Because of rapid biotransformation of verapamil during its first pass through the portal circulation, bioavailability ranges from 20% to 35%.
      9. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:d23c757d-39f8-48c3-ba63-df2cbe58c516 (opens source in a new tab)

        Verapamil label

        Version not recorded · Effective date not recorded

        Because of rapid biotransformation of verapamil during its first pass through the portal circulation, bioavailability ranges from 20% to 35%.
      10. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:febce7aa-7f5a-e0c1-e053-6394a90aebc4 (opens source in a new tab)

        Verapamil label

        Version not recorded · Effective date not recorded

        Because of rapid biotransformation of verapamil during its first pass through the portal circulation, bioavailability ranges from 20% to 35%.
      11. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:f7814f9a-e589-4041-e053-6294a90a29e3 (opens source in a new tab)

        Verapamil label

        Version not recorded · Effective date not recorded

        Because of rapid biotransformation of verapamil during its first pass through the portal circulation, bioavailability ranges from 20% to 35%.
      12. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:f9399858-fd7a-4b73-8759-3e5bf3af2666 (opens source in a new tab)

        Verapamil label

        Version not recorded · Effective date not recorded

        Because of rapid biotransformation of verapamil during its first pass through the portal circulation, the absolute bioavailability ranges from 20% to 35%.
      13. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:f88dfe56-08bc-46b1-8f05-f886a16a89bc (opens source in a new tab)

        Verapamil label

        Version not recorded · Effective date not recorded

        Because of rapid biotransformation of verapamil during its first pass through the portal circulation, bioavailability ranges from 20% to 35%.
      14. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:2f839b5c-b8e7-40df-887f-7df94326fc7b (opens source in a new tab)

        Verapamil label

        Version not recorded · Effective date not recorded

        Because of rapid biotransformation of verapamil during its first pass through the portal circulation, bioavailability ranges from 20% to 35%.
      15. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:fe05b8d8-fdee-903b-e053-6394a90a2e05 (opens source in a new tab)

        Verapamil label

        Version not recorded · Effective date not recorded

        Because of rapid biotransformation of verapamil during its first pass through the portal circulation, bioavailability ranges from 20% to 35%.
      16. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:3283bba6-05dd-3766-e063-6394a90ada69 (opens source in a new tab)

        Verapamil label

        Version not recorded · Effective date not recorded

        Because of rapid biotransformation of verapamil during its first pass through the portal circulation, bioavailability ranges from 20% to 35%.
      17. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:522bafc3-4352-4840-b296-e399202c4162 (opens source in a new tab)

        Verapamil label

        Version not recorded · Effective date not recorded

        Because of rapid biotransformation of verapamil during its first pass through the portal circulation, the absolute bioavailability ranges from 20% to 35%.
      18. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:af1249b0-e889-4f02-bdc2-54862de0545e (opens source in a new tab)

        Verapamil label

        Version not recorded · Effective date not recorded

        Because of rapid biotransformation of verapamil during its first pass through the portal circulation, bioavailability ranges from 20% to 35%.
      19. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:bf7b5037-7355-4788-b17b-323c18a5aee7 (opens source in a new tab)

        Verapamil label

        Version not recorded · Effective date not recorded

        Because of rapid biotransformation of verapamil during its first pass through the portal circulation, the absolute bioavailability ranges from 20% to 35%.
      20. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:a0343397-897b-46d6-943f-a87e07e1de10 (opens source in a new tab)

        Verapamil label

        Version not recorded · Effective date not recorded

        Because of rapid biotransformation of verapamil during its first pass through the portal circulation, bioavailability ranges from 20% to 35%.
      21. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:4ffa579e-1d85-4b3b-ae06-6a9334e0f9e1 (opens source in a new tab)

        Verapamil label

        Version not recorded · Effective date not recorded

        Because of rapid biotransformation of verapamil during its first pass through the portal circulation, bioavailability ranges from 20% to 35%.
      22. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:ed1e0c14-3571-43f9-88fc-5a4d2b598263 (opens source in a new tab)

        Verapamil label

        Version not recorded · Effective date not recorded

        Because of rapid biotransformation of verapamil during its first pass through the portal circulation, bioavailability ranges from 20% to 35%.
      23. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:d4a6c046-81fe-4b2a-9cb0-adb3f037eec7 (opens source in a new tab)

        Verapamil label

        Version not recorded · Effective date not recorded

        Because of rapid biotransformation of verapamil during its first pass through the portal circulation, bioavailability ranges from 20% to 35%.
      24. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:1de6ad5c-942e-4381-b01f-e5e63bbf72ef (opens source in a new tab)

        Verapamil label

        Version not recorded · Effective date not recorded

        Because of rapid biotransformation of verapamil during its first pass through the portal circulation, bioavailability ranges from 20% to 35%.
      25. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:ed182ebe-8299-4680-9dea-ef79d30db683 (opens source in a new tab)

        Verapamil label

        Version not recorded · Effective date not recorded

        Because of rapid biotransformation of verapamil during its first pass through the portal circulation, bioavailability ranges from 20% to 35%.
      26. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:0742cf97-601b-4c13-a6c3-1a6a616ed292 (opens source in a new tab)

        Verapamil label

        Version not recorded · Effective date not recorded

        Because of rapid biotransformation of verapamil during its first pass through the portal circulation, the absolute bioavailability ranges from 20% to 35%.
      27. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:e36e485f-fbed-4e30-9a63-984931f2e54e (opens source in a new tab)

        Verapamil label

        Version not recorded · Effective date not recorded

        Because of rapid biotransformation of verapamil during its first pass through the portal circulation, bioavailability ranges from 20% to 35%.
      28. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:3bee2d26-138c-4641-a217-a38d3d657461 (opens source in a new tab)

        Verapamil label

        Version not recorded · Effective date not recorded

        Because of rapid biotransformation of verapamil during its first pass through the portal circulation, the absolute bioavailability ranges from 20% to 35%.
      29. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:343724eb-e80b-4729-80e7-6b8028713ea1 (opens source in a new tab)

        Verapamil label

        Version not recorded · Effective date not recorded

        Because of rapid biotransformation of verapamil during its first pass through the portal circulation, bioavailability ranges from 20% to 35%.
      30. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:006cf920-04ae-0b53-cb91-85481972abc2 (opens source in a new tab)

        Verapamil label

        Version not recorded · Effective date not recorded

        Because of rapid biotransformation of verapamil during its first pass through the portal circulation, bioavailability ranges from 20% to 35%.
      31. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:c635f442-2349-4820-877a-a42e5f0a44b5 (opens source in a new tab)

        Verapamil label

        Version not recorded · Effective date not recorded

        Because of rapid biotransformation of verapamil during its first pass through the portal circulation, bioavailability ranges from 20% to 35%.
      32. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:fe0583bf-9986-e01e-e053-6294a90a0b26 (opens source in a new tab)

        Verapamil label

        Version not recorded · Effective date not recorded

        Because of rapid biotransformation of verapamil during its first pass through the portal circulation, bioavailability ranges from 20% to 35%.
      33. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:62c3aadf-412e-41a5-9e57-2c48d962f90a (opens source in a new tab)

        Verapamil label

        Version not recorded · Effective date not recorded

        Because of rapid biotransformation of verapamil during its first pass through the portal circulation, bioavailability ranges from 20% to 35%.
      34. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:660a83a9-60be-42d5-bc70-fe384e93beaa (opens source in a new tab)

        Verapamil label

        Version not recorded · Effective date not recorded

        Because of rapid biotransformation of verapamil during its first pass through the portal circulation, bioavailability ranges from 20% to 35%.
      35. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:fdb7cd57-d33c-f5a3-e053-6294a90aff31 (opens source in a new tab)

        Verapamil label

        Version not recorded · Effective date not recorded

        Because of rapid biotransformation of verapamil during its first pass through the portal circulation, bioavailability ranges from 20% to 35%.
      36. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:b0eeada4-1010-4c11-b408-29f9a1af23c0 (opens source in a new tab)

        Verapamil label

        Version not recorded · Effective date not recorded

        Because of rapid biotransformation of verapamil during its first pass through the portal circulation, bioavailability ranges from 20% to 35%.
      37. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:e19ab8d8-dae5-489d-9805-7e7407bea06d (opens source in a new tab)

        Verapamil label

        Version not recorded · Effective date not recorded

        Because of rapid biotransformation of verapamil during its first pass through the portal circulation, bioavailability ranges from 20% to 35%.
      38. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:3f14442c-8178-0bad-e054-00144ff8d46c (opens source in a new tab)

        Verapamil label

        Version not recorded · Effective date not recorded

        Because of rapid biotransformation of verapamil during its first pass through the portal circulation, bioavailability ranges from 20% to 35%.
      39. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:19cb23bd-cc6d-45fc-a1fc-b4130ea460a6 (opens source in a new tab)

        Verapamil label

        Version not recorded · Effective date not recorded

        Because of rapid biotransformation of verapamil during its first pass through the portal circulation, bioavailability ranges from 20% to 35%.
      40. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:2712ab16-122b-4f44-a687-e2cb3c04019e (opens source in a new tab)

        Verapamil label

        Version not recorded · Effective date not recorded

        Because of rapid biotransformation of verapamil during its first pass through the portal circulation, bioavailability ranges from 20% to 35%.
      41. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:a6de732a-fe48-486d-bb05-0a9fff6f42d7 (opens source in a new tab)

        Verapamil label

        Version not recorded · Effective date not recorded

        Because of rapid biotransformation of verapamil during its first pass through the portal circulation, bioavailability ranges from 20% to 35%.
      42. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:db990ce1-b193-4a81-e053-2a95a90a627b (opens source in a new tab)

        Verapamil label

        Version not recorded · Effective date not recorded

        Because of rapid biotransformation of verapamil during its first pass through the portal circulation, bioavailability ranges from 20% to 35%.
      43. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:adc77fea-db39-aac5-e053-2995a90ad458 (opens source in a new tab)

        Verapamil label

        Version not recorded · Effective date not recorded

        Because of rapid biotransformation of verapamil during its first pass through the portal circulation, bioavailability ranges from 20% to 35%.
      44. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:2f232216-db62-4dc6-a5a7-9139d7ac7589 (opens source in a new tab)

        Verapamil label

        Version not recorded · Effective date not recorded

        Because of rapid biotransformation of verapamil during its first pass through the portal circulation, bioavailability ranges from 20% to 35%.
      45. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:0b00ec93-0bb3-4181-a6ef-45206f0621f7 (opens source in a new tab)

        Verapamil label

        Version not recorded · Effective date not recorded

        Because of rapid biotransformation of verapamil during its first pass through the portal circulation, bioavailability ranges from 20% to 35%.
      46. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:9d529fe3-7b5c-4dde-9a8c-440a969df359 (opens source in a new tab)

        Verapamil label

        Version not recorded · Effective date not recorded

        Because of rapid biotransformation of verapamil during its first pass through the portal circulation, bioavailability ranges from 20% to 35%.
      47. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:c86084bc-33aa-eece-5a96-6c0dad2d1a32 (opens source in a new tab)

        Verapamil label

        Version not recorded · Effective date not recorded

        Because of rapid biotransformation of verapamil during its first pass through the portal circulation, the absolute bioavailability ranges from 20% to 35%.
      48. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:5467dad4-f3ba-4036-b5f4-4d2d4d5abc34 (opens source in a new tab)

        Verapamil label

        Version not recorded · Effective date not recorded

        Because of rapid biotransformation of verapamil during its first pass through the portal circulation, bioavailability ranges from 20% to 35%.
      49. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:7b321aa1-1b53-26d5-e053-2991aa0a1373 (opens source in a new tab)

        Verapamil label

        Version not recorded · Effective date not recorded

        Because of rapid biotransformation of verapamil during its first pass through the portal circulation, bioavailability ranges from 20% to 35%.
      50. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:a58f5f77-7e88-d622-e053-2a95a90a0d35 (opens source in a new tab)

        Verapamil label

        Version not recorded · Effective date not recorded

        Because of rapid biotransformation of verapamil during its first pass through the portal circulation, bioavailability ranges from 20% to 35%.
      51. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:3c215e6c-d85a-4102-a1c2-f00fa3169a55 (opens source in a new tab)

        Verapamil label

        Version not recorded · Effective date not recorded

        Because of rapid biotransformation of verapamil during its first pass through the portal circulation, bioavailability ranges from 20% to 35%.
      52. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:a32f346e-71cf-cc11-e053-2a95a90ae88c (opens source in a new tab)

        Verapamil label

        Version not recorded · Effective date not recorded

        Because of rapid biotransformation of verapamil during its first pass through the portal circulation, bioavailability ranges from 20% to 35%.
      53. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:f2f059a1-0cf9-a5d6-e053-2a95a90a3dab (opens source in a new tab)

        Verapamil label

        Version not recorded · Effective date not recorded

        Because of rapid biotransformation of verapamil during its first pass through the portal circulation, bioavailability ranges from 20% to 35%.
      54. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:e07b3574-9259-4f64-a9ae-f4e0e64800b6 (opens source in a new tab)

        Verapamil label

        Version not recorded · Effective date not recorded

        Because of rapid biotransformation of verapamil during its first pass through the portal circulation, bioavailability ranges from 20% to 35%.
      55. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:ce9ab27a-e03b-4e40-a0e0-b586cd75dead (opens source in a new tab)

        Verapamil label

        Version not recorded · Effective date not recorded

        Because of rapid biotransformation of verapamil during its first pass through the portal circulation, bioavailability ranges from 20% to 35%.

    2. 33%

      Numeric value
      33
      Unit
      %
      Source records
      2

      Population and context: Unknown: population and formulation context were not structurally extracted from this source sentence.

      Show all 2 source records
      1. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:18f6d349-8c5c-4443-ac65-16bf6619ecdc (opens source in a new tab)

        Verapamil label

        Version not recorded · Effective date not recorded

        Absorption: In a study in 5 subjects with oral immediate-release verapamil, the systemic bioavailability was from 33% to 65% for the R enantiomer and from 13% to 34% for the S enantiomer.
      2. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:5f665d08-e1e4-422a-88c2-d8834abf9e1a (opens source in a new tab)

        Verapamil label

        Version not recorded · Effective date not recorded

        Absorption: In a study in 5 subjects with oral immediate-release verapamil, the systemic bioavailability was from 33% to 65% for the R enantiomer and from 13% to 34% for the S enantiomer.

  8. Projected row 1628

    Medicine slug
    verapamil
    Compared field
    halfLife
    Comparison state
    insufficient_context
    Reason codes
    • STRUCTURED_CONTEXT_MISSING
    Documents examined
    93
    Source count
    80
    Agreement rate
    0.6125
    Recorded readings

    1. 2.8 to 7.4 hours

      Numeric value
      2.8
      Unit
      hours
      Source records
      49

      Population and context: Unknown: population and formulation context were not structurally extracted from this source sentence.

      Show all 49 source records
      1. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:c7a54ee0-80c0-4c7e-a6a3-cb60142f860c (opens source in a new tab)

        Verapamil label

        Version not recorded · Effective date not recorded

        The mean elimination half-life in single-dose studies ranged from 2.8 to 7.4 hours.
      2. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:d7c29dfd-3968-41ac-a081-e670f9bd605c (opens source in a new tab)

        Verapamil label

        Version not recorded · Effective date not recorded

        The mean elimination half-life in single-dose studies ranged from 2.8 to 7.4 hours.
      3. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:ba1bf1ae-9347-4d17-998b-14bf7b5984ce (opens source in a new tab)

        Verapamil label

        Version not recorded · Effective date not recorded

        The mean elimination half-life in single-dose studies ranged from 2.8 to 7.4 hours.
      4. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:ebc9a09a-7b5f-4df6-ace7-31185d469b28 (opens source in a new tab)

        Verapamil label

        Version not recorded · Effective date not recorded

        The mean elimination half-life in single-dose studies ranged from 2.8 to 7.4 hours.
      5. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:e08c07bf-58b4-6fa2-e053-2a95a90aca32 (opens source in a new tab)

        Verapamil label

        Version not recorded · Effective date not recorded

        The mean elimination half-life in single-dose studies ranged from 2.8 to 7.4 hours.
      6. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:5dc5f087-c8da-4ed0-b532-ae44508958aa (opens source in a new tab)

        Verapamil label

        Version not recorded · Effective date not recorded

        The mean elimination half-life in single-dose studies ranged from 2.8 to 7.4 hours.
      7. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:5501208c-aa2b-47aa-89f7-87f4d4a73fd0 (opens source in a new tab)

        Verapamil label

        Version not recorded · Effective date not recorded

        The mean elimination half-life in single-dose studies ranged from 2.8 to 7.4 hours.
      8. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:f00c1caf-68b6-40c1-a1fa-72d17d2cf44f (opens source in a new tab)

        Verapamil label

        Version not recorded · Effective date not recorded

        The mean elimination half-life in single-dose studies ranged from 2.8 to 7.4 hours.
      9. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:d23c757d-39f8-48c3-ba63-df2cbe58c516 (opens source in a new tab)

        Verapamil label

        Version not recorded · Effective date not recorded

        The mean elimination half-life in single-dose studies ranged from 2.8 to 7.4 hours.
      10. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:febce7aa-7f5a-e0c1-e053-6394a90aebc4 (opens source in a new tab)

        Verapamil label

        Version not recorded · Effective date not recorded

        The mean elimination half-life in single-dose studies ranged from 2.8 to 7.4 hours.
      11. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:f7814f9a-e589-4041-e053-6294a90a29e3 (opens source in a new tab)

        Verapamil label

        Version not recorded · Effective date not recorded

        The mean elimination half-life in single-dose studies ranged from 2.8 to 7.4 hours.
      12. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:f88dfe56-08bc-46b1-8f05-f886a16a89bc (opens source in a new tab)

        Verapamil label

        Version not recorded · Effective date not recorded

        The mean elimination half-life in single-dose studies ranged from 2.8 to 7.4 hours.
      13. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:2f839b5c-b8e7-40df-887f-7df94326fc7b (opens source in a new tab)

        Verapamil label

        Version not recorded · Effective date not recorded

        The mean elimination half-life in single-dose studies ranged from 2.8 to 7.4 hours.
      14. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:fe05b8d8-fdee-903b-e053-6394a90a2e05 (opens source in a new tab)

        Verapamil label

        Version not recorded · Effective date not recorded

        The mean elimination half-life in single-dose studies ranged from 2.8 to 7.4 hours.
      15. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:3283bba6-05dd-3766-e063-6394a90ada69 (opens source in a new tab)

        Verapamil label

        Version not recorded · Effective date not recorded

        The mean elimination half-life in single-dose studies ranged from 2.8 to 7.4 hours.
      16. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:af1249b0-e889-4f02-bdc2-54862de0545e (opens source in a new tab)

        Verapamil label

        Version not recorded · Effective date not recorded

        The mean elimination half-life in single-dose studies ranged from 2.8 to 7.4 hours.
      17. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:a0343397-897b-46d6-943f-a87e07e1de10 (opens source in a new tab)

        Verapamil label

        Version not recorded · Effective date not recorded

        The mean elimination half-life in single-dose studies ranged from 2.8 to 7.4 hours.
      18. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:4ffa579e-1d85-4b3b-ae06-6a9334e0f9e1 (opens source in a new tab)

        Verapamil label

        Version not recorded · Effective date not recorded

        The mean elimination half-life in single-dose studies ranged from 2.8 to 7.4 hours.
      19. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:ed1e0c14-3571-43f9-88fc-5a4d2b598263 (opens source in a new tab)

        Verapamil label

        Version not recorded · Effective date not recorded

        The mean elimination half-life in single-dose studies ranged from 2.8 to 7.4 hours.
      20. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:d4a6c046-81fe-4b2a-9cb0-adb3f037eec7 (opens source in a new tab)

        Verapamil label

        Version not recorded · Effective date not recorded

        The mean elimination half-life in single-dose studies ranged from 2.8 to 7.4 hours.
      21. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:1de6ad5c-942e-4381-b01f-e5e63bbf72ef (opens source in a new tab)

        Verapamil label

        Version not recorded · Effective date not recorded

        The mean elimination half-life in single-dose studies ranged from 2.8 to 7.4 hours.
      22. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:ed182ebe-8299-4680-9dea-ef79d30db683 (opens source in a new tab)

        Verapamil label

        Version not recorded · Effective date not recorded

        The mean elimination half-life in single-dose studies ranged from 2.8 to 7.4 hours.
      23. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:e36e485f-fbed-4e30-9a63-984931f2e54e (opens source in a new tab)

        Verapamil label

        Version not recorded · Effective date not recorded

        The mean elimination half-life in single-dose studies ranged from 2.8 to 7.4 hours.
      24. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:343724eb-e80b-4729-80e7-6b8028713ea1 (opens source in a new tab)

        Verapamil label

        Version not recorded · Effective date not recorded

        The mean elimination half-life in single-dose studies ranged from 2.8 to 7.4 hours.
      25. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:006cf920-04ae-0b53-cb91-85481972abc2 (opens source in a new tab)

        Verapamil label

        Version not recorded · Effective date not recorded

        The mean elimination half-life in single-dose studies ranged from 2.8 to 7.4 hours.
      26. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:c635f442-2349-4820-877a-a42e5f0a44b5 (opens source in a new tab)

        Verapamil label

        Version not recorded · Effective date not recorded

        The mean elimination half-life in single-dose studies ranged from 2.8 to 7.4 hours.
      27. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:fe0583bf-9986-e01e-e053-6294a90a0b26 (opens source in a new tab)

        Verapamil label

        Version not recorded · Effective date not recorded

        The mean elimination half-life in single-dose studies ranged from 2.8 to 7.4 hours.
      28. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:62c3aadf-412e-41a5-9e57-2c48d962f90a (opens source in a new tab)

        Verapamil label

        Version not recorded · Effective date not recorded

        The mean elimination half-life in single-dose studies ranged from 2.8 to 7.4 hours.
      29. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:660a83a9-60be-42d5-bc70-fe384e93beaa (opens source in a new tab)

        Verapamil label

        Version not recorded · Effective date not recorded

        The mean elimination half-life in single-dose studies ranged from 2.8 to 7.4 hours.
      30. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:fdb7cd57-d33c-f5a3-e053-6294a90aff31 (opens source in a new tab)

        Verapamil label

        Version not recorded · Effective date not recorded

        The mean elimination half-life in single-dose studies ranged from 2.8 to 7.4 hours.
      31. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:b0eeada4-1010-4c11-b408-29f9a1af23c0 (opens source in a new tab)

        Verapamil label

        Version not recorded · Effective date not recorded

        The mean elimination half-life in single-dose studies ranged from 2.8 to 7.4 hours.
      32. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:e19ab8d8-dae5-489d-9805-7e7407bea06d (opens source in a new tab)

        Verapamil label

        Version not recorded · Effective date not recorded

        The mean elimination half-life in single-dose studies ranged from 2.8 to 7.4 hours.
      33. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:3f14442c-8178-0bad-e054-00144ff8d46c (opens source in a new tab)

        Verapamil label

        Version not recorded · Effective date not recorded

        The mean elimination half-life in single-dose studies ranged from 2.8 to 7.4 hours.
      34. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:19cb23bd-cc6d-45fc-a1fc-b4130ea460a6 (opens source in a new tab)

        Verapamil label

        Version not recorded · Effective date not recorded

        The mean elimination half-life in single-dose studies ranged from 2.8 to 7.4 hours.
      35. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:2712ab16-122b-4f44-a687-e2cb3c04019e (opens source in a new tab)

        Verapamil label

        Version not recorded · Effective date not recorded

        The mean elimination half-life in single-dose studies ranged from 2.8 to 7.4 hours.
      36. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:a6de732a-fe48-486d-bb05-0a9fff6f42d7 (opens source in a new tab)

        Verapamil label

        Version not recorded · Effective date not recorded

        The mean elimination half-life in single-dose studies ranged from 2.8 to 7.4 hours.
      37. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:db990ce1-b193-4a81-e053-2a95a90a627b (opens source in a new tab)

        Verapamil label

        Version not recorded · Effective date not recorded

        The mean elimination half-life in single-dose studies ranged from 2.8 to 7.4 hours.
      38. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:adc77fea-db39-aac5-e053-2995a90ad458 (opens source in a new tab)

        Verapamil label

        Version not recorded · Effective date not recorded

        The mean elimination half-life in single-dose studies ranged from 2.8 to 7.4 hours.
      39. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:2f232216-db62-4dc6-a5a7-9139d7ac7589 (opens source in a new tab)

        Verapamil label

        Version not recorded · Effective date not recorded

        The mean elimination half-life in single-dose studies ranged from 2.8 to 7.4 hours.
      40. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:0b00ec93-0bb3-4181-a6ef-45206f0621f7 (opens source in a new tab)

        Verapamil label

        Version not recorded · Effective date not recorded

        The mean elimination half-life in single-dose studies ranged from 2.8 to 7.4 hours.
      41. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:9d529fe3-7b5c-4dde-9a8c-440a969df359 (opens source in a new tab)

        Verapamil label

        Version not recorded · Effective date not recorded

        The mean elimination half-life in single-dose studies ranged from 2.8 to 7.4 hours.
      42. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:5467dad4-f3ba-4036-b5f4-4d2d4d5abc34 (opens source in a new tab)

        Verapamil label

        Version not recorded · Effective date not recorded

        The mean elimination half-life in single-dose studies ranged from 2.8 to 7.4 hours.
      43. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:7b321aa1-1b53-26d5-e053-2991aa0a1373 (opens source in a new tab)

        Verapamil label

        Version not recorded · Effective date not recorded

        The mean elimination half-life in single-dose studies ranged from 2.8 to 7.4 hours.
      44. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:a58f5f77-7e88-d622-e053-2a95a90a0d35 (opens source in a new tab)

        Verapamil label

        Version not recorded · Effective date not recorded

        The mean elimination half-life in single-dose studies ranged from 2.8 to 7.4 hours.
      45. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:3c215e6c-d85a-4102-a1c2-f00fa3169a55 (opens source in a new tab)

        Verapamil label

        Version not recorded · Effective date not recorded

        The mean elimination half-life in single-dose studies ranged from 2.8 to 7.4 hours.
      46. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:a32f346e-71cf-cc11-e053-2a95a90ae88c (opens source in a new tab)

        Verapamil label

        Version not recorded · Effective date not recorded

        The mean elimination half-life in single-dose studies ranged from 2.8 to 7.4 hours.
      47. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:f2f059a1-0cf9-a5d6-e053-2a95a90a3dab (opens source in a new tab)

        Verapamil label

        Version not recorded · Effective date not recorded

        The mean elimination half-life in single-dose studies ranged from 2.8 to 7.4 hours.
      48. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:e07b3574-9259-4f64-a9ae-f4e0e64800b6 (opens source in a new tab)

        Verapamil label

        Version not recorded · Effective date not recorded

        The mean elimination half-life in single-dose studies ranged from 2.8 to 7.4 hours.
      49. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:ce9ab27a-e03b-4e40-a0e0-b586cd75dead (opens source in a new tab)

        Verapamil label

        Version not recorded · Effective date not recorded

        The mean elimination half-life in single-dose studies ranged from 2.8 to 7.4 hours.

    2. 2 to 5 hours

      Numeric value
      2
      Unit
      hours
      Source records
      23

      Population and context: Unknown: population and formulation context were not structurally extracted from this source sentence.

      Show all 23 source records
      1. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:df77b8d1-1d2b-4fea-a1e9-153bd25008a6 (opens source in a new tab)

        Verapamil label

        Version not recorded · Effective date not recorded

        Following intravenous infusion in man, verapamil is eliminated bi-exponentially, with a rapid early distribution phase (half-life about 4 minutes) and a slower terminal elimination phase (half-life 2 to 5 hours).
      2. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:c87c7f7e-cdf5-42c7-a831-a7515d2d51d6 (opens source in a new tab)

        Verapamil label

        Version not recorded · Effective date not recorded

        Following intravenous infusion in man, verapamil is eliminated bi-exponentially, with a rapid early distribution phase (half-life about 4 minutes) and a slower terminal elimination phase (half-life 2 to 5 hours).
      3. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:74d94dbf-0567-6c15-e053-2991aa0ac6e4 (opens source in a new tab)

        Verapamil label

        Version not recorded · Effective date not recorded

        Following intravenous infusion in man, verapamil is eliminated bi-exponentially, with a rapid early distribution phase (half-life about 4 minutes) and a slower terminal elimination phase (half-life 2 to 5 hours).
      4. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:9650680c-89ae-451b-aa75-4d34158866e7 (opens source in a new tab)

        Verapamil label

        Version not recorded · Effective date not recorded

        Following intravenous infusion in man, verapamil is eliminated bi-exponentially, with a rapid early distribution phase (half-life about 4 minutes) and a slower terminal elimination phase (half-life 2 to 5 hours).
      5. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:386ae2d7-ddf7-a753-e063-6294a90ab45e (opens source in a new tab)

        Verapamil label

        Version not recorded · Effective date not recorded

        Following intravenous infusion in man, verapamil is eliminated bi-exponentially, with a rapid early distribution phase (half-life about 4 minutes) and a slower terminal elimination phase (half-life 2 to 5 hours).
      6. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:df79ee3a-f0ed-1cc7-e053-2995a90af97f (opens source in a new tab)

        Verapamil label

        Version not recorded · Effective date not recorded

        Following intravenous infusion in man, verapamil hydrochloride is eliminated bi-exponentially, with a rapid early distribution phase (half-life about 4 minutes) and a slower terminal elimination phase (half-life 2 to 5 hours).
      7. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:951c7fd7-10ef-2b07-e053-2995a90aaffd (opens source in a new tab)

        Verapamil label

        Version not recorded · Effective date not recorded

        Following intravenous infusion in man, verapamil is eliminated bi-exponentially, with a rapid early distribution phase (half-life about 4 minutes) and a slower terminal elimination phase (half-life 2 to 5 hours).
      8. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:1076a3ef-de02-487f-8117-b4e80495db29 (opens source in a new tab)

        Verapamil label

        Version not recorded · Effective date not recorded

        Following intravenous infusion in man, verapamil is eliminated bi-exponentially, with a rapid early distribution phase (half-life about 4 minutes) and a slower terminal elimination phase (half-life 2 to 5 hours).
      9. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:9c89764e-ff07-4077-a40f-91eb1c179af2 (opens source in a new tab)

        Verapamil label

        Version not recorded · Effective date not recorded

        Following intravenous infusion in man, verapamil is eliminated bi-exponentially, with a rapid early distribution phase (half-life about 4 minutes) and a slower terminal elimination phase (half-life 2 to 5 hours).
      10. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:03c5daf8-5399-4d89-a747-9a9d7667b6e4 (opens source in a new tab)

        Verapamil label

        Version not recorded · Effective date not recorded

        Following intravenous infusion in man, verapamil is eliminated bi-exponentially, with a rapid early distribution phase (half-life about 4 minutes) and a slower terminal elimination phase (half-life 2 to 5 hours).
      11. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:9055ed6b-f466-4f38-a9d9-f22e9ac97ad4 (opens source in a new tab)

        Verapamil label

        Version not recorded · Effective date not recorded

        Following intravenous infusion in man, verapamil is eliminated bi-exponentially, with a rapid early distribution phase (half-life about 4 minutes) and a slower terminal elimination phase (half-life 2 to 5 hours).
      12. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:e18cc04c-a808-4d92-9b66-762cd787abc5 (opens source in a new tab)

        Verapamil label

        Version not recorded · Effective date not recorded

        Following intravenous infusion in man, verapamil is eliminated bi-exponentially, with a rapid early distribution phase (half-life about 4 minutes) and a slower terminal elimination phase (half-life 2 to 5 hours).
      13. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:d7a749d0-4ab3-4fbb-8d7b-e09d68413c41 (opens source in a new tab)

        Verapamil label

        Version not recorded · Effective date not recorded

        Following intravenous infusion in man, verapamil is eliminated bi-exponentially, with a rapid early distribution phase (half-life about 4 minutes) and a slower terminal elimination phase (half-life 2 to 5 hours).
      14. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:1c993365-1b62-4524-e781-d307f28f63bc (opens source in a new tab)

        Verapamil label

        Version not recorded · Effective date not recorded

        Following intravenous infusion in man, verapamil is eliminated bi-exponentially, with a rapid early distribution phase (half-life about 4 minutes) and a slower terminal elimination phase (half-life 2 to 5 hours).
      15. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:3318e357-0660-44f4-8170-91a51bd762fb (opens source in a new tab)

        Verapamil label

        Version not recorded · Effective date not recorded

        Following intravenous infusion in man, verapamil is eliminated bi-exponentially, with a rapid early distribution phase (half-life about 4 minutes) and a slower terminal elimination phase (half-life 2-5 hours).
      16. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:def3b9ba-523d-4b83-a80d-fa6f362e111c (opens source in a new tab)

        Verapamil label

        Version not recorded · Effective date not recorded

        Following intravenous infusion in man, verapamil hydrochloride is eliminated bi-exponentially, with a rapid early distribution phase (half-life about 4 minutes) and a slower terminal elimination phase (half-life 2 to 5 hours).
      17. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:38ca9270-5538-467a-a3e9-c27968f3aafe (opens source in a new tab)

        Verapamil label

        Version not recorded · Effective date not recorded

        Following intravenous infusion in man, verapamil is eliminated bi-exponentially, with a rapid early distribution phase (half-life about 4 minutes) and a slower terminal elimination phase (half-life 2 to 5 hours).
      18. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:424f538f-8785-8279-e063-6394a90aeb4c (opens source in a new tab)

        Verapamil label

        Version not recorded · Effective date not recorded

        Following intravenous infusion in man, verapamil is eliminated bi-exponentially, with a rapid early distribution phase (half-life about 4 minutes) and a slower terminal elimination phase (half-life 2 to 5 hours).
      19. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:70057a53-ca29-4848-ab3d-5e691e2a14a3 (opens source in a new tab)

        Verapamil label

        Version not recorded · Effective date not recorded

        Following intravenous infusion in man, verapamil is eliminated bi-exponentially, with a rapid early distribution phase (half-life about 4 minutes) and a slower terminal elimination phase (half-life 2 to 5 hours).
      20. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:6685248d-908e-cd07-e053-2a91aa0ac718 (opens source in a new tab)

        Verapamil label

        Version not recorded · Effective date not recorded

        Following intravenous infusion in man, verapamil is eliminated bi-exponentially, with a rapid early distribution phase (half-life about 4 minutes) and a slower terminal elimination phase (half-life 2-5 hours).
      21. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:a9a1a522-231b-41a1-95c6-0c75dbb62f47 (opens source in a new tab)

        Verapamil label

        Version not recorded · Effective date not recorded

        Following intravenous infusion in man, verapamil is eliminated bi-exponentially, with a rapid early distribution phase (half-life about 4 minutes) and a slower terminal elimination phase (half-life 2 to 5 hours).
      22. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:eff5e83b-f819-4a5b-9746-12bce328d7a7 (opens source in a new tab)

        Verapamil label

        Version not recorded · Effective date not recorded

        Following intravenous infusion in man, verapamil is eliminated bi-exponentially, with a rapid early distribution phase (half-life about 4 minutes) and a slower terminal elimination phase (half-life 2-5 hours).
      23. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:a76b2cff-7029-4607-88db-9921ec2842b6 (opens source in a new tab)

        Verapamil label

        Version not recorded · Effective date not recorded

        Following intravenous infusion in man, verapamil is eliminated bi-exponentially, with a rapid early distribution phase (half-life about 4 minutes) and a slower terminal elimination phase (half-life 2 to 5 hours).

    3. 12 hours

      Numeric value
      12
      Unit
      hours
      Source records
      6

      Population and context: Unknown: population and formulation context were not structurally extracted from this source sentence.

      Show all 6 source records
      1. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:f9399858-fd7a-4b73-8759-3e5bf3af2666 (opens source in a new tab)

        Verapamil label

        Version not recorded · Effective date not recorded

        Similarly the apparent half-life (t 1/2 ) has been found to be approximately 12 hours independent of dose.
      2. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:522bafc3-4352-4840-b296-e399202c4162 (opens source in a new tab)

        Verapamil label

        Version not recorded · Effective date not recorded

        Similarly the apparent half-life (t 1/2 ) has been found to be approximately 12 hours independent of dose.
      3. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:bf7b5037-7355-4788-b17b-323c18a5aee7 (opens source in a new tab)

        Verapamil label

        Version not recorded · Effective date not recorded

        Similarly the apparent half-life (t 1/2 ) has been found to be approximately 12 hours independent of dose.
      4. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:0742cf97-601b-4c13-a6c3-1a6a616ed292 (opens source in a new tab)

        Verapamil label

        Version not recorded · Effective date not recorded

        Similarly the apparent half-life (t 1/2 ) has been found to be approximately 12 hours independent of dose.
      5. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:3bee2d26-138c-4641-a217-a38d3d657461 (opens source in a new tab)

        Verapamil label

        Version not recorded · Effective date not recorded

        Similarly the apparent half-life (t 1/2 ) has been found to be approximately 12 hours independent of dose.
      6. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:c86084bc-33aa-eece-5a96-6c0dad2d1a32 (opens source in a new tab)

        Verapamil label

        Version not recorded · Effective date not recorded

        Similarly the apparent half-life (t 1/2 ) has been found to be approximately 12 hours independent of dose.

    4. 14 to 16 hours

      Numeric value
      14
      Unit
      hours
      Source records
      2

      Population and context: Unknown: population and formulation context were not structurally extracted from this source sentence.

      Show all 2 source records
      1. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:18f6d349-8c5c-4443-ac65-16bf6619ecdc (opens source in a new tab)

        Verapamil label

        Version not recorded · Effective date not recorded

        In patients with hepatic insufficiency, metabolism of immediate-release verapamil is delayed and elimination half-life prolonged up to 14 to 16 hours because of the extensive hepatic metabolism [see Use in Specific Populations ( 8.6 ) ].
      2. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:5f665d08-e1e4-422a-88c2-d8834abf9e1a (opens source in a new tab)

        Verapamil label

        Version not recorded · Effective date not recorded

        In patients with hepatic insufficiency, metabolism of immediate-release verapamil is delayed and elimination half-life prolonged up to 14 to 16 hours because of the extensive hepatic metabolism [ see Use in Specific Populations (8.6) ].

  9. Projected row 1629

    Medicine slug
    verapamil
    Compared field
    tMax
    Comparison state
    insufficient_context
    Reason codes
    • STRUCTURED_CONTEXT_MISSING
    Documents examined
    93
    Source count
    8
    Agreement rate
    0.75
    Recorded readings

    1. 7-9 hours

      Numeric value
      7
      Unit
      hours
      Source records
      6

      Population and context: Unknown: population and formulation context were not structurally extracted from this source sentence.

      Show all 6 source records
      1. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:f9399858-fd7a-4b73-8759-3e5bf3af2666 (opens source in a new tab)

        Verapamil label

        Version not recorded · Effective date not recorded

        The time to reach maximum verapamil concentrations (T max ) with Verapamil Hydrochloride Sustained-Release Capsules has been found to be approximately 7-9 hours in each of the single dose (fasting), single dose (fed), the multiple dose (steady state) studies and dose proportionality pharmacokinetic studies.
      2. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:522bafc3-4352-4840-b296-e399202c4162 (opens source in a new tab)

        Verapamil label

        Version not recorded · Effective date not recorded

        The time to reach maximum verapamil concentrations (T max ) with Verapamil Hydrochloride Sustained-Release Capsules has been found to be approximately 7-9 hours in each of the single dose (fasting), single dose (fed), the multiple dose (steady state) studies and dose proportionality pharmacokinetic studies.
      3. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:bf7b5037-7355-4788-b17b-323c18a5aee7 (opens source in a new tab)

        Verapamil label

        Version not recorded · Effective date not recorded

        The time to reach maximum verapamil concentrations (T max ) with verapamil hydrochloride extended-release capsules have been found to be approximately 7-9 hours in each of the single dose (fasting), single dose (fed), the multiple dose (steady state) studies and dose proportionality pharmacokinetic studies.
      4. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:0742cf97-601b-4c13-a6c3-1a6a616ed292 (opens source in a new tab)

        Verapamil label

        Version not recorded · Effective date not recorded

        The time to reach maximum verapamil concentrations (T max ) with Verapamil Hydrochloride Sustained-Release Capsules has been found to be approximately 7-9 hours in each of the single dose (fasting), single dose (fed), the multiple dose (steady state) studies and dose proportionality pharmacokinetic studies.
      5. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:3bee2d26-138c-4641-a217-a38d3d657461 (opens source in a new tab)

        Verapamil label

        Version not recorded · Effective date not recorded

        The time to reach maximum verapamil concentrations (T max ) with verapamil hydrochloride extended-release capsules have been found to be approximately 7-9 hours in each of the single dose (fasting), single dose (fed), the multiple dose (steady state) studies and dose proportionality pharmacokinetic studies.
      6. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:c86084bc-33aa-eece-5a96-6c0dad2d1a32 (opens source in a new tab)

        Verapamil label

        Version not recorded · Effective date not recorded

        The time to reach maximum verapamil concentrations (T max ) with verapamil hydrochloride extended-release capsules have been found to be approximately 7-9 hours in each of the single dose (fasting), single dose (fed), the multiple dose (steady state) studies and dose proportionality pharmacokinetic studies.

    2. 11 hours

      Numeric value
      11
      Unit
      hours
      Source records
      2

      Population and context: Unknown: population and formulation context were not structurally extracted from this source sentence.

      Show all 2 source records
      1. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:18f6d349-8c5c-4443-ac65-16bf6619ecdc (opens source in a new tab)

        Verapamil label

        Version not recorded · Effective date not recorded

        The drug release phase is prolonged with the peak plasma concentration (C max ) occurring approximately 11 hours after administration.
      2. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:5f665d08-e1e4-422a-88c2-d8834abf9e1a (opens source in a new tab)

        Verapamil label

        Version not recorded · Effective date not recorded

        The drug release phase is prolonged with the peak plasma concentration (C max ) occurring approximately 11 hours after administration.

  10. Projected row 1630

    Medicine slug
    vigabatrin
    Compared field
    halfLife
    Comparison state
    insufficient_context
    Reason codes
    • STRUCTURED_CONTEXT_MISSING
    Documents examined
    25
    Source count
    25
    Agreement rate
    0.84
    Recorded readings

    1. 5.7 hours

      Numeric value
      5.7
      Unit
      hours
      Source records
      21

      Population and context: Unknown: population and formulation context were not structurally extracted from this source sentence.

      Show all 21 source records
      1. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:0afdc84c-f8ec-330a-31c9-fac4ed256931 (opens source in a new tab)

        Vigabatrin label

        Version not recorded · Effective date not recorded

        The terminal half-life of vigabatrin is about 5.7 hours for infants (5 months to 2 years of age), 6.8 hours for children (3 years to 9 years of age), 9.5 hours for children and adolescents (10 to 16 years of age) and 10.5 hours for adults.
      2. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:ee835fb6-2b2b-40c4-b6d7-0ad0e790cda8 (opens source in a new tab)

        Vigabatrin label

        Version not recorded · Effective date not recorded

        The terminal half-life of vigabatrin is about 5.7 hours for infants (5 months to 2 years of age), 6.8 hours for children (3 to 9 years of age), 9.5 hours for children and adolescents (10 to 16 years of age), and 10.5 hours for adults.
      3. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:04fef2ec-c275-405d-91b1-99a74ee8caa2 (opens source in a new tab)

        Vigabatrin label

        Version not recorded · Effective date not recorded

        The terminal half-life of vigabatrin is about 5.7 hours for infants (5 months to 2 years of age), 6.8 hours for children (3 to 9 years of age), 9.5 hours for children and adolescents (10 to 16 years of age), and 10.5 hours for adults.
      4. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:9791494f-492b-487a-8211-7747fb57923e (opens source in a new tab)

        Vigabatrin label

        Version not recorded · Effective date not recorded

        The terminal half-life of vigabatrin is about 5.7 hours for infants (5 months to 2 years of age), 6.8 hours for children (3 to 9 years of age), 9.5 hours for children and adolescents (10 years to 16 years of age), and 10.5 hours for adults.
      5. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:5ed8d293-b7d8-4c66-9c31-8075e6f99092 (opens source in a new tab)

        Vigabatrin label

        Version not recorded · Effective date not recorded

        The terminal half-life of vigabatrin is about 5.7 hours for infants (5 months to 2 years of age), 6.8 hours for children (3 to 9 years of age), 9.5 hours for children and adolescents (10 to 16 years of age), and 10.5 hours for adults.
      6. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:a5d389d2-d0e1-4395-a2a2-b552808e7f98 (opens source in a new tab)

        Vigabatrin label

        Version not recorded · Effective date not recorded

        The terminal half-life of vigabatrin is about 5.7 hours for infants (5 months to 2 years of age), 6.8 hours for children (3 to 9 years of age), 9.5 hours for children and adolescents (10 to 16 years of age), and 10.5 hours for adults.
      7. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:a88ac1b4-e2c9-45c0-b321-4785902172e3 (opens source in a new tab)

        Vigabatrin label

        Version not recorded · Effective date not recorded

        The terminal half-life of vigabatrin is about 5.7 hours for infants (5 months to 2 years of age), 6.8 hours for children (3 to 9 years of age), 9.5 hours for children and adolescents (10 to 16 years of age), and 10.5 hours for adults.
      8. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:823cc915-0350-4780-85ed-cd1c338e429d (opens source in a new tab)

        Vigabatrin label

        Version not recorded · Effective date not recorded

        The terminal half-life of vigabatrin is about 5.7 hours for infants (5 months to 2 years of age), 6.8 hours for children (3 to 9 years of age), 9.5 hours for children and adolescents (10 to 16 years of age), and 10.5 hours for adults.
      9. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:5b8fb137-848b-45fd-9107-a6db5a675360 (opens source in a new tab)

        Vigabatrin label

        Version not recorded · Effective date not recorded

        The terminal half-life of vigabatrin is about 5.7 hours for infants (5 months to 2 years of age), 6.8 hours for children (3 to 9 years of age), 9.5 hours for children and adolescents (10 years to 16 years of age), and 10.5 hours for adults.
      10. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:c97ce40c-1c5a-479d-9188-5ce03cf7e065 (opens source in a new tab)

        Vigabatrin label

        Version not recorded · Effective date not recorded

        The terminal half-life of vigabatrin is about 5.7 hours for infants (5 months to 2 years of age), 6.8 hours for children (3 to 9 years of age), 9.5 hours for children and adolescents (10 to 16 years of age), and 10.5 hours for adults.
      11. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:8d3d6316-33ab-41e8-9485-4495c218be56 (opens source in a new tab)

        Vigabatrin label

        Version not recorded · Effective date not recorded

        The terminal half-life of vigabatrin is about 5.7 hours for infants (5 months to 2 years of age).
      12. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:01f7f049-78c2-47c2-a66e-ec662ba48a98 (opens source in a new tab)

        Vigabatrin label

        Version not recorded · Effective date not recorded

        The terminal half-life of vigabatrin is about 5.7 hours for infants (5 months to 2 years of age), 6.8 hours for children (3 to 9 years of age), 9.5 hours for children and adolescents (10 to 16 years of age) and 10.5 hours for adults.
      13. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:93ba3894-fd97-4432-9f2d-e7050371e91f (opens source in a new tab)

        Vigabatrin label

        Version not recorded · Effective date not recorded

        The terminal half-life of vigabatrin is about 5.7 hours for infants (5 months to 2 years of age), 6.8 hours for children (3 to 9 years of age), 9.5 hours for children and adolescents (10 to 16 years of age), and 10.5 hours for adults.
      14. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:e7cbc0a5-8c28-4451-9176-b608e228ba66 (opens source in a new tab)

        Vigabatrin label

        Version not recorded · Effective date not recorded

        The terminal half-life of vigabatrin is about 5.7 hours for infants (5 months to 2 years of age), 6.8 hours for children (3 to 9 years of age), 9.5 hours for children and adolescents (10 to 16 years of age), and 10.5 hours for adults.
      15. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:bda491b6-47ba-400b-9816-b6d15c6e2683 (opens source in a new tab)

        Vigabatrin label

        Version not recorded · Effective date not recorded

        The terminal half-life of vigabatrin is about 5.7 hours for infants (5 months to 2 years of age), 6.8 hours for children (3 to 9 years of age), 9.5 hours for children and adolescents (10 to 16 years of age), and 10.5 hours for adults.
      16. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:f6be436e-46c7-e9ab-0fcf-e8d04dc12b72 (opens source in a new tab)

        Vigabatrin label

        Version not recorded · Effective date not recorded

        The terminal half-life of vigabatrin is about 5.7 hours for infants (5 months to 2 years of age), 6.8 hours for children (3 to 9 years of age), 9.5 hours for children and adolescents (10 to 16 years of age), and 10.5 hours for adults.
      17. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:6d3fc853-1b2d-47ad-a4f2-f11505601bc2 (opens source in a new tab)

        Vigabatrin label

        Version not recorded · Effective date not recorded

        The terminal half-life of vigabatrin is about 5.7 hours for infants (5 months to 2 years of age), 6.8 hours for children (3 to 9 years of age), 9.5 hours for children and adolescents (10 to 16 years of age), and 10.5 hours for adults.
      18. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:082d818a-4f4e-4675-98c6-91db0294e63c (opens source in a new tab)

        Vigabatrin label

        Version not recorded · Effective date not recorded

        The terminal half-life of vigabatrin is about 5.7 hours for infants (5 months to 2 years of age), 6.8 hours for children (3 to 9 years of age), 9.5 hours for children and adolescents (10 to 16 years of age), and 10.5 hours for adults.
      19. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:cd5ebc7a-8d5b-46b4-ad9b-e4a25fa3e26c (opens source in a new tab)

        Vigabatrin label

        Version not recorded · Effective date not recorded

        The terminal half-life of vigabatrin is about 5.7 hours for infants (5 months to 2 years of age), 6.8 hours for children (3 to 9 years of age), 9.5 hours for children and adolescents (10 to 16 years of age), and 10.5 hours for adults.
      20. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:5e5e7554-d0f4-47f7-a434-cc5ca5a9826f (opens source in a new tab)

        Vigabatrin label

        Version not recorded · Effective date not recorded

        The terminal half-life of vigabatrin is about 5.7 hours for infants (5 months to 2 years of age), 6.8 hours for children (3 to 9 years of age), 9.5 hours for children and adolescents (10 to 16 years of age) and 10.5 hours for adults.
      21. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:8406bd5a-8887-4579-a11e-5ab449c58963 (opens source in a new tab)

        Vigabatrin label

        Version not recorded · Effective date not recorded

        The terminal half-life of vigabatrin is about 5.7 hours for infants (5 months to 2 years of age), 6.8 hours for children (3 to 9 years of age), 9.5 hours for children and adolescents (10 to 16 years of age), and 10.5 hours for adults.

    2. 6.8 hours

      Numeric value
      6.8
      Unit
      hours
      Source records
      4

      Population and context: Unknown: population and formulation context were not structurally extracted from this source sentence.

      Show all 4 source records
      1. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:8dc7bd15-2636-4d58-b651-dd117ca43dbd (opens source in a new tab)

        Vigabatrin label

        Version not recorded · Effective date not recorded

        The terminal half-life of vigabatrin is about 6.8 hours for children (3 to 9 years of age), 9.5 hours for children and adolescents (10 to 16 years of age), and 10.5 hours for adults.
      2. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:6c0bf4fb-b234-4053-9163-1e8d0142d718 (opens source in a new tab)

        Vigabatrin label

        Version not recorded · Effective date not recorded

        The terminal half-life of vigabatrin is about 6.8 hours for children (3 to 9 years of age), 9.5 hours for children and adolescents (10 to 16 years of age), and 10.5 hours for adults.
      3. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:4aaea88b-e0fd-45e3-bb02-604bf8ee9b5b (opens source in a new tab)

        Vigabatrin label

        Version not recorded · Effective date not recorded

        The terminal half-life of vigabatrin is about 6.8 hours for children (3 to 9 years of age), 9.5 hours for children and adolescents (10 to 16 years of age), and 10.5 hours for adults.
      4. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:e9c99000-fc0c-4083-b620-ba9ac821f8ac (opens source in a new tab)

        Vigabatrin label

        Version not recorded · Effective date not recorded

        The terminal half-life of vigabatrin is about 6.8 hours for children (3 to 9 years of age), 9.5 hours for children and adolescents (10 to 16 years of age), and 10.5 hours for adults.

Access

Query or download the projection

View this filtered page as JSONDownload up to 200 filtered CSV rows
GET /api/datasets/source-consensus?limit=10&offset=1620

Allowed query parameters

q
Case-insensitive text search over the public fields named for this dataset.
state
Exact comparability state.Values: agree, differ, not_comparable, insufficient_context
field
Exact recorded field key.Values: bioavailability, halfLife, proteinBinding, tMax, volumeOfDistribution
limit / offset
Pagination is required. limit is at most 200; offset is bounded. Set format=csv for the same projected page as a download.

Reuse and corrections

Keep the boundary attached

CC BY 4.0 applies to RNAWiki licenses its selection, schema, structure, and derived projection. Quoted source passages and third-party records retain their original rights.

Cite RNAWiki, this dataset identifier, and the generated date. Keep the “does not mean” statement with any downstream display so a corpus measurement is not mistaken for medical advice.

Read the correction policy